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ABSTRACT 
 
 Microfluidic technology is a useful tool to help answer unsolved problems in 
multidisciplinary fields, including molecular biology, clinical pathology and the 
pharmaceutical industry.Current microfluidic based devices with diverse structures have 
been constructed via extensively used soft lithography orphotolithography fabrication 
methods. A layer-by-layer stacking of 2D planar microchannel arrays can achieve a 
limited degree of three dimensionality. However, assembly of large-scale multi-tiered 
structures is tedious, and the inherently planar nature of the individual layers restricts the 
network’s topological complexity. In order to overcome the limitations of existing 
microfabrication methodswe demonstrate several novel methods that enable 
microvasculature networks: electrostatic discharge,global channel deformation and 
enzymatic sculpting to fabricate complex surface topologies.  
 These methods enable construction of networks of branched microchannels 
arranged in a tree-like architecture with diameters ranging from approximately 10 µm to 
1 mm. Interconnected networks with multiple fluidic access points can be 
straightforwardly constructed, and quantification of their branching characteristics 
reveals remarkable similarity to naturally occurring vasculature. In addition, by 
harnessing enzymatic micromachining we are able to construct nanochannels, 
microchannels containing embedded features templated by the substrate’s crystalline 
morphology, and an irregular cross section of microchannel capable of performing 
isolation and enrichment of cells from whole blood with throughput 1 – 2 orders of 
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magnitude faster than currently possible. These techniques can play a key role in 
developing an organ-sized engineered tissue scaffolds and high-throughput continuous 
flow separations. 
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NOMENCLATURE 
 
2D Two dimensional 
3D Three dimensional 
CTC Circulating tumor cell 
EC Endothelial cell 
ECM Extracellular matrix 
κ Dean number 
PDMS  Poly(dimethylsiloxane) 
PK  Proteinase K 
PLA Poly(lactic acid) 
PMMA Poly(methyl methacrylate) 
RBC Red blood cell 
Re Reynolds number 
SEM  Scanning electron microscopy 
SMC Smooth muscle cell 
WBC White blood cell 
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CHAPTER I 
INTRODUCTION  
 
1.1 Overview 
Microenvironments throughout nature incorporate complex topologies that assist 
in orchestrating a host of physical and biological functions, particularly in the presence 
of flow where phenomena at surfaces and in the bulk fluid are often strongly 
coupled.Current models have been developed to mimic these distinctive features which 
can be applied,for example, to fabricatean artificial microvascular network for tissue 
engineering applications via softlithography1, 2.Similarly, intricately-shaped surface 
features can be exploited to establish flow fields capable of providing enhanced transport 
that has proven beneficial in applications like micromixing3-5. Despite their importance, 
however, many of these structured features and surfaces are challenging to build using 
existing micromachining methods.The goal of my research is (1) to develop the 
fabrication technologies to overcome one of the greatest obstacles in the field of tissue 
engineering by mimicking the vasculature network inside organ-size biomaterial 
scaffoldsand (2) to establish an innovative microfluidic-base filtration method capable of 
performing simultaneous size-based isolation and enrichment of circulating tumor cells.I 
hypothesized that a fabricated microvascular network and constructed complex 
topologiescan be used both to transport nutrients to maintain the viability of cells and to 
separate cancer cells from the blood stream. 
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1.2 MicrovascularNetwork 
Interest in developing new capabilities to engineer artificial tissue and organ 
structures suitable for implantation has intensified during the past decade owing to 
theirenormous untapped lifesaving potential. Health care costs related to organ failure 
are staggering, easily extending into the hundreds of billions of dollars in the US alone—
a situation compounded by the fact that transplantation is often the only viable 
therapeutic option in many cases (e.g. acute physical trauma, severe burns, etc.)6. A 
well-known example is cardiovascular disease, a condition impacting over 80 million 
adults in the US, contributing to 1 out of every 3 deaths in 20077. These problems are 
expected to grow over the coming years as overall life expectancies increase, as 
evidenced by the fact that the waiting list for donor organs in the US has doubled in size 
during the past 20 years. In 2010, out of a total of 110,942 patients on the transplantation 
waiting list in the US, however,only 22,104 received organs and 6,521 died awaiting a 
suitable donor (Organ Procurement and Transplantation Network, 
http://optn.transplant.hrsa.gov/). Engineered organ replacements offer a compelling 
alternative to address this growing need. 
A major barrier to production of organ-sized tissue constructs is the challengeof 
designing scaffold microenvironments that are capable of providing sufficient nutrient 
delivery and waste removal throughout extended three-dimensional volumes8-12. 
Incredible progress has been made toward development of porous biodegradable 
scaffolds for tissue culture13-15, but transport within these scaffolds primarily occurs by 
molecular diffusion—a passive and inherently slow process. This fundamental limitation 
 3 
 
effectively restricts the maximum thickness of engineered tissues to 100 – 200 µm16, 17, 
beyond which cells in the interior remain nutrient limited and die18, 19. In nature, vascular 
networks have evolved to elegantly address this problem by incorporating highly 
branched fractal-like architectures that are efficiently space-filling while minimizing the 
energy required to sustain transport20, 21. Metabolically active cells in the body, for 
example, are often located no more than 50 – 100 µm away from a capillary bed. In 
addition to functioning as local nutrient and waste sinks, the specific microstructure and 
positioning of these capillary networks provide cues that help orchestrate the 
organization and differentiation of cells within the tissue structure. Consequently, the 
ability to embed functional capillary networks within tissue engineering scaffolds would 
represent a significant step toward manufacturing organ-sized constructs in vitro22, 23. 
 
1.2.1 Characteristics of branched vascular networks 
Naturally occurring vascular networks are notoriously challenging to replicate 
artificially owing to their unique complexity, characterized by a well-defined global 
architecture that persists despite the fact that no two networks are completely identical at 
all structural levels. However, despite these variations, there is self-similarity expressed 
in terms of parameters related to a network’s branching characteristics (average 
branching angle, diameter ratio and symmetry between parent and daughter branches, 
fractal dimension, etc.). One of these key parameters more directly related to transport 
efficiency can be obtained by considering a balance between the energy needed to 
sustain flow through a conduit versus the energy required to produce enough fluid to fill 
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its volume. This analysis yields a relationship known as Murray’s law, predicting that an 
optimal system-wide state of uniform shear stress corresponds to a global scaling of flow 
rate with the cube of microchannel diameter24-27. Specifically, in the case of a parent 
channel of diameter d0 bifurcating into two daughter channels with diameters d1 and d2, 
Murray’s law implies that d0k = d1k + d2k where a value of k = 3 is predicted under ideal 
conditions (e.g., laminar, non-pulsatile flow). In physiological systems, values of the 
branching exponent k generally range between 2 and 3 depending on location within the 
network (e.g., data from porcine vasculature display scaling exponents of k = 2.82 for d0 
≤ 40 µm, k = 2.50 for 40 <d0 ≤ 200 µm, and k = 2.35 for d0> 200 µm)28-30. Other notable 
examples include human pulmonary vasculature (k ~ 2.531) and the pig coronary arterial 
tree (k ~ 2.232). These deviations from the ideal k = 3 scaling arise in part because 
pulsatile flow generally dominates in the larger diameter vessels (e.g., aorta and major 
arteries), where area-preserving branching (k = 2) helps to minimize wave reflections at 
the branching points33. Smaller vessels, on the other hand, maintain exponents closer to k 
= 3 because the need to maintain the blood flow with minimal energy consumption 
becomes a dominant consideration21. 
 
1.2.2 Fabrication of 2D microvascular networks 
Although methods currently exist to artificially construct analogs of individual 
large blood vessels, the formation of the much smaller diameter capillaries is more 
challenging. Photolithography-based micromachining methods have recently emerged as 
valuable tools to enable construction of microfluidic and 
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microelectromechanicalsystems. These same processes offer a natural avenue to 
construct vascular-mimicking networks by allowing complex microscale geometries to 
be fashioned in planar substrates (Table 1.1). In the early 2000s, Vacanti and co-workers 
pioneered some of the first applications of these methods to produce microvascular 
topologies in silicon wafers, which subsequently served as rigid molds to imprint the 
patterned networks into biodegradable polymers like poly(lactic-co-glycolic acid) 
(PLGA)2, 34, 35. This process, typically referred to as soft lithography, involves the 
following basic sequence of steps: (1) spin coating photoresist onto the surface of clean 
silicon wafers, (2) patterning the photoresist by exposure to UV light through a 
photomask, (3) developing the pattern by exposure to a chemical that selectively 
removes the photoresist in areas exposed to the UV light, (4) etching the network pattern 
into the silicon substrate, and (5) stripping away the remaining photoresist. The resulting 
silicon wafer now contains a negative imprint of the desired microchannel pattern that 
then serves as a rigid mold or master against which a positive replica can be cast in the 
desired substrate material (in this case by pouring molten PLGA onto the surface and 
peeling it away after solidification). The patterned polymer is then bonded to a flat 
surface to create enclosed microchannels36.  
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Table 1.1.Summary of literature reporting construction of 2D microvascular 
networks. 
(Publications from the same laboratory are grouped together) 
 
Channel 
cross-
section 
Channel 
size range Micromachining method 
Construction 
time 
Substrate 
material(s) 
Substrate 
size Reference 
rectangular 20-60 µm electroforming - 
polycarbonate, 
poly lactide-
coglycolides 
1 x 2 cm2 37
 
rectangular 20-60 µm photoresist based molding - PMMA, PDMS 1 x 2 cm2 38
 
circular 60-120 µm photoresist based molding 
and bonding - PDMS 1 x 2 cm
2
 
39
 
rectangular 5-300 µm micro-patterning - 
collagen-
glycosaminoglyca
n membrane 
1.7 mm 
thickness 
40
 
rectangular 100 µm-5 
mm 
soft lithography - PDMS 1 x 2 cm2 41
 
semi-circular 40-120 µm wet etching 5 h silicon 7.5 x 2.5 
cm2 
42
 
rectangular 6-50 µm soft lithography with 
sacrificial element 5 h gelatin 85 cm
2
 
43
 
rectangular 45µm-3mm soft lithography ~ 5 days poly(glycerol 
sebacate) 
3.8 x 7.5 x 
0.1 cm3 
1
 
rectangular 10-500 µm wet/plasma etching - silicon and Pyrex 10 cm2 35
 
rectangular 35 µm-5 
mm 
lithographic and 
etching followed by soft 
lithography 
4 h PDMS 2 x 4 cm2 44, 45
 
rectangular - wet/plasma etching - silicon 
mold/PLGA 5 x 5 cm
2
 
34
 
rectangular 50-1000 µm 
soft lithography, molding 
agarose to wafer then 
sealing two layers of 
agarose together 
- 
agarose with or 
without cell 
encapsulation 
1 cm 
thickness 
46
 
rectangular 100 µm 
soft lithography, injection of 
alginate and cells, sealing of 
hydrogel layers to form 
channels 
- 
calcium alginate 
hydrogel seeded 
with chondrocytes 
1 x 1cm2 47
 
rectangular 6-63 µm soft lithography - PDMS - 48
 
rectangular 267-727 µm 
electric discharge machining 
of stainless steel mold, then 
soft lithography to cast in 
PDMS 
- PDMS 
circle, 130 
mm 
diameter 
49
 
rectangular 20 µm-2.73 
mm 
micromachining of stainless 
steel mold then soft 
lithography to cast in PDMS 
- PDMS 5 x 5 cm2 50
 
rectangular 1.197 mm soft lithography - PDMS 2 x 2 cm2 51
 
round 80-190 µm 
electroplating of silicon 
master mold, then micro-
patterning 
- polystyrene 1 x 3 cm2 52
 
rectangular 50-400 µm UV exposure to polymer through mask pattern - pCLLA acrylate - 
53
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Table 1.1. Continued 
 
Channel 
cross-
section 
Channel 
size range Micromachining method 
Construction 
time 
Substrate 
material(s) 
Substrate 
size Reference 
rectangular 125-660 µm 
laser nanosecond ablation 
followed by chemical wet 
etching 
- silicon 1.5 cm 54, 55
 
semi-circular 50 µm-1 
mm 
laser ablation followed by 
chemical wet etching 8 h 
silicon mold/ 
PDMS channel 1 cm 
56
 
rectangular 
90-600 µm 
hydraulic 
diameter 
femtosecond laser ablation 
followed by chemical wet 
etching 
5 h silicon 3 x 6 cm2 57
 
round 100 µm inkjet printing of cells - fibrin 2 x 8 mm2 58
 
rectangular 40-60 µm hydrogel constructs cast from PDMS mold - 
alginate, collagen 
I, Matrigel I, fibrin 1 x 2 mm
2
 
59
 
round 
< 10 µm or 
larger if co-
cultured 
laser guided direct writing 
weeks, if co-
culturing with 
hepatocytes 
Matrigel, collagen 0.5 mm thickness 
60
 
 
 
 
Variations of this basic soft lithography method have enabled microvascular-
mimicking flow networks to be constructed in a variety of substrate materials suitable 
for cell culture. Poly(dimethyl siloxane) (PDMS) is one of the most widely used 
substrates owing to a number of favorable properties including optical transparency and 
gas permeability44, 45, but more recent studies have explored a wider range of materials. 
For example, Fidkowskiet al. synthesized a rubber-like biodegradable polymer, 
poly(glycerol sebacate) (PGS), and applied it to construct an endothelialized capillary 
network using human umbilical vein endothelial cells (HUVECs) (Fig.1.1a)1. A number 
of hydrogel substrates have also been investigated, including argarose46, alginate (Fig. 
1.1b)47, and collagen/alginate (Fig. 1.1c)59. Linget al. demonstrated that flow networks 
embedded in agarose can efficiently provide nutrient and waste exchange for 
surrounding cells46. Choiet al. investigated metabolite (e.g. calcein-AM) delivery in cell-
seeded alginate hydrogels47, while Gilletteetal. demonstrated in situ collagen fiber 
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assembly in a cell-seeded hydrogel59. Additional complexity can be introduced by 
machining channels with variable depths, accomplished by processes such as laser 
machining into silicon followed by acid etching (Fig.1.1d)54-57. Although not fully three 
dimensional, the ability to vary the depth enables construction of networks with 
architectures that more closely follow the scalings predicted by Murray’s law61, 62. 
Another novel approach was demonstrated by Cui and Boland, who constructed micron-
sized fibrin channels using drop-on-demand polymerization implemented via an inkjet 
printing process, and subsequently demonstrated successful cell culture for up to 21 days 
in the resulting microchannel network (Fig.1.1e)58. 
 
1.2.3 Fabrication of 3D microvascular networks 
Although vascularized microfluidic networks are readily produced in 2D by 
photolithographic or soft-lithographic techniques, comparable progress toward 
constructing 3D networks has occurred only recently (Table 1.2). This capability is of 
interest because it is generally recognized that 3D culture environments more closely 
replicate physiological conditions in vitro than 2D cultures. The simplest approach to 
generate 3D architectures involves stacking multiple 2D vascularized layers in a 
fluidically interconnected arrangement2, 63, 64(Fig. 1.2a-c). For example, Bettingeret al. 
assembled five microfluidic layers constructed in a biodegradable substrate to create a 
3D tissue culture scaffold, which was then seeded with a high density of HepG2 cells 
that formed aggregates throughout the microchannels63. 
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Figure 1.1.Construction of 2D microvascular networks. Soft lithography methods 
enable networks to be constructed in a variety of substrates including (a) PGS 
(reproduced with permission from reference1), (b) alginate (reproduced with permission 
from reference47), and (c) collagen/alginate (reproduced with permission from 
reference59). Other construction methods include (d) laser machining (reproduced with 
permission from reference57), and (e) inkjet printing (reproduced with permission from 
reference58). 
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The capacity for long-term viability was assessed by measuring albumin 
secretion rates. Kniazevaet al. employed a similar approach to construct individual 
blood-gas subunits that could be stacked together to form a microfluidic respiratory 
assist device to study gas permeance in artificial lung applications64. 
Lewis and coworkers have pioneered a novel approach involving direct writing 
of organic inks to create 3D microvascular networks in a Pluronic F127-diacrylate (DA) 
hydrogel65 (Fig. 1.2d). In this approach, the ink is precisely dispensed using a fine 
nozzle positioned by a robotically controlled multi-axis stage so that 3D structures can 
be produced in a layer-by-layer fashion. After encapsulation in a desired substrate, the 
fugitive ink is liquefied and removed by application of a modest vacuum, leaving a 
microchannel network embedded in the surrounding matrix66-70. 
Other research projects have applied similar direct writing methods based on 
fusing multicellular spheroid aggregates containing various cell types (e.g. smooth 
muscle, fibroblasts) into tubular structures which serve as building blocks within a 
molding template (Fig. 1.2e)71, 72. Layer-by-layer deposition of these components 
permits the resulting tube diameter, wall thickness, and branching pattern to be 
accurately controlled. These scaffold-free constructs offer an alternative approach to 
enable tissue culture in expanded 3D volumes. 
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Table 1.2.Summary of literature reporting construction of 3D microvascular 
networks. 
(Publications from the same laboratory are grouped together) 
 
Channel 
cross-
section 
Channel size 
range 
Micromachining 
method 
Construction 
time 
Substrate 
material(s) 
Substrate 
size Reference 
varied 
 
 
100 µm soft lithography - PDMS 1 mm thick 73
 
rectangular 10 µm-1 cm wet/plasma etching - silicon 
mold/PLGA 5 x 5 cm
2
 
2
 
rectangular 35 µm-5 mm soft lithography - PDMS 3 x 3 x 5 cm3 64
 
circular 0.9-2.5 mm 
deposition of bioink 
particles into tubular 
structures using 
bioprinter 
2-4 days agarose  71
 
circular varied cell sheet engineering 3-7 days NHDF and HUVEC sheets 60 µm 
74
 
circular 30 µm 
co-seeding HUVEC and 
10 T1/2 precursor cells in 
vivo 
up to 2 weeks collagen gel 165 µm 75
 
circular 30-45 nm 
culturing HUVEC on 
ionic self-assembling 
peptide gels 
2 days peptide gel 500 µm 76
 
varied varied modular assembly of HUVEC coated cylinders 3 days 
collagen-HepG2 
cylinders 
0.57 mm 
diameter, 
1.8 mm long 
77
 
circular 230 µm direct-write assembly - epoxy resin  66
 
circular 200 µm direct-write assembly - epoxy resin 20 x 20 x 20 
mm3 
67
 
circular 100-500 µm direct-write assembly - epoxy resin 40 x 40 x 5 
mm3 
68
 
circular 200-600 µm direct-write assembly - 
Pluronic F127 
diacrylate 
(F127-DA) 
40 x 20 x 1 
mm3 
65
 
rectangular 200 µm direct-write assembly - epoxy resin 45 x 7 x 10 
mm3 
69
 
circular 
vertical: 100-
410 µm 
 
dual ink deposition and 
vertical ink writing - epoxy resin 
50 x 12 x 6 
mm3 
70
 
trapezoidal 200 µm 
photolithographic and 
plasma-etching to 
produce silicon master 
- 
poly(glycerol 
sebacate) 
10 x 5 x 1 
mm3 
63
 
circular 1-100 µm sacrificial sugar 
structures - polycaprolactone 
1 x 2 x 0.5 
cm3 
78, 79
 
rectangular 400 µm layer by layer direct printing - collagen 
5 x 5 x 1 
mm3 
80
 
circular 10 µm-1 mm electrostatic discharge seconds PMMA, PLA 25 x 10 x 10 
mm3 
81
 
varied 15-20 µm 
angiogenesis in three 
layers of fibroblast sheets 
in vitro 
15-31 days 
Fibroblasts, 
keratinocytes, 
HUVEC or 
HMVEC 
3 x 3 cm2 82, 83
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Figure 1.2.Construction of 3D microvascular networks.(a) Stacking of 2D PLGA-
based micro-patterns (reproduced with permission from reference2). (b) Stacking of 2D 
PGS-based micro-patterns (reproduced with permission from reference63). (c) Stacking 
of 2D PDMS-based micro-patterns (reproduced with permission from reference64). (d) 
Embedding of vasculature within a Pluronic F127-based construct by direct-write 
assembly (reproduced with permission from reference65). (e) Deposition of bioink 
particles into tubular structures using a bioprinter (reproduced with permission from 
reference71). (f) Network constructed using a sacrificial sugar process (reproduced with 
permission from reference78, 79). (g) Tree-like branched network fabricated in PLA using 
electrostatic discharge (reproduced with permission from reference81). (h) 
Vasculogenesis by co-seeding HUVEC and 10 T1/2 precursor cells in vivo (reproduced 
with permission from reference75). 
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Sacrificial techniques have also been developed to construct microvascular 
networks. Golden and Tien demonstrated the ability to embed complex 2D networks 
within hydrogels by lithographic patterning of gelatin as a sacrificial element43. Leeet al. 
extended this concept into 3D by printing a heated gelatin solution between collagen 
layers80. A novel albeit unconventional approach was employed by 
embeddingmicrovascular networks within PDMS, epoxy, polycaprolactoneand other 
hydrogel matrices using melt-spun sugar fibers and carbohydrate glass as the sacrificial 
elements(Fig. 1.2f)78, 79. 
A key drawback associated with many of these methods is that the microchannels 
produced generally possess a relatively narrow range of diameters, rendering them less 
representative of physiologically relevant vascular systems where diameters become 
progressively smaller from the base to the tips of the branched network. One novel 
approach to mimic this architecture involves using electrostatic discharge (Fig. 1.2g)81. 
This process harnesses electron beam irradiation to implant a high level of electric 
charge inside an insulating polymeric substrate so that the energy released upon 
discharge will be sufficiently intense to locally vaporize and fracture the surrounding 
material. In this way, networks of highly branched tree-like microchannels with 
diameters ranging from approximately 10 µm to 1 mm are produced that become 
permanently embedded within the substrate. These networks incorporate branching 
characteristics quantitatively similar to naturally occurring vasculature, and have been 
successfully produced in both in both poly(methyl methacrylate) (PMMA) and 
biodegradable poly(lactic acid) (PLA) substrates. 
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In addition to manufacturing scaffolds with embedded vasculature, progress has 
also been made toward inducing formation of microvascular networks by directed 
differentiation of vascular endothelial cells and vascular progenitors (e.g. angioblasts), a 
process called vasculogenesis84. Although the resulting blood vessels sometimes become 
immature and unstable85, Jain and coworkers have demonstrated the ability to produce a 
long-lasting blood vessel network (functional for one year) by co-culturing vascular 
endothelial cells and mesenchymal precursor cells (Fig. 1.2h)75. Finally, a promising 
approach based on decellularization of allogeneic or xenogeneic donor organs has been 
explored to reconstruct a variety of tissues including heart86, liver87, lung88-90, and blood 
vessels91. The decellularization process yields an acellular3D scaffold directly 
replicating its natural counterpart that can subsequently be re-seeded with either 
functional parenchymal cells or selected progenitor cell populations. Initial results have 
shown promise, however, challenges associated with fibrosis of the in vivo cultured 
constructs after implantation as well as the need to rely on donor organs to provide a 
source for each decellularized construct still remain to be overcome. 
 
1.2.4 Microchannel topologies 
Ideally, microfluidic channels comprising vascular networks should incorporate 
circular cross-sectional profiles mimicking those in natural vasculature. But 
conventional lithographic and molding techniques are generally only capable of creating 
square, rectangular, or trapezoidal cross-sections. Despite these limitations, the ease with 
which 2D microchannel networks can be constructed using soft lithography has led it to 
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become one of the most widely used micromachining methods1, 2, 34, 35, 44, 45. Other 
approaches including electroforming37, laser ablation57, and sacrificial elements43 have 
also been used to produce 2D branched networks with rectangular cross-sectional 
profiles. These studies have been proven useful to reveal key features associated with 
metabolite and oxygen exchange, waste dispersal, flow behavior, and extracellular 
matrix (ECM) formation that are critical to understand in order to undertake long term 
cell culture.  
Despite these successes, however, the use of non-circular cross-sections for these 
studies poses challenges because the sharp corners are difficult to seed uniformly92, 
making it difficult to form the confluent layers necessary to produce fully 
endothelialized networks. Moreover, wall shear stresses can vary widely across the 
width of microchannels with rectangular or trapezoidal cross-sections93, as well as in the 
vicinity of flow obstructions94. Since these local shear stresses play an important role in 
governing functional phenotype and gene expression in endothelial cells95-97, the extent 
to which experiments using these geometries faithfully replicate the physiological 
microenvironment must be considered.  
Other area where microfluidic networks have provided useful insights is in 
studies investigating blood clotting phenomena (both in initial98 and propagation99 
phases) that contribute to venous and arterial thrombosis according to Virchow’s triad 
describing venous thrombosis in terms of an interplay among effects related to (1) vessel 
wall damage, (2) blood flow changes, and (3) alterations in the blood’s fluidic 
characteristics100.  
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Recent advances in micromachining technology have made it possible to 
construct semi-circular topologies by applying methods such as photoresist-based 
molding39, wet etching42, electroplated molding52, laser ablation56, and micromilling101. 
Microchannels with circular cross-sections are then constructed by aligning two 
substrates imprinted with complementary semi-circular patterns and bonding them 
together. Direct-ink writing methods have also been employed to construct 3D branched 
networks with circular cross-sectional profiles in hydrogel matrices65. The electrostatic 
discharge method also shows promise to enable 3D networks with circular cross-section 
topologies to be embedded in larger substrates81.  
In addition to the cross-sectional profile of individual microchannels, the 
branching architecture of the global network should match that of the physiological 
system of interest (Table 1.3). This can be accomplished by applying Murray’s law to 
determine hierarchy of changes in diameter that should be experienced by microchannels 
entering and exiting each branch point. These concepts have been applied to design and 
construct branched microvascular networks in both 2D42, 49, 50, 54-57, 102and 3D64, 68, 81. But 
while providing an important guide, Murray’s law is not the only consideration because 
in reality the wall shear stress (WSS) values display variability in physiological systems 
depending on the particular location within the flow network. For example, mean WSS 
values were found to range on average between 1.1 – 1.4 Pa in the common carotid 
artery, whereas values in the 0.5 – 5.0 Pa range are found in arterioles larger than 15 µm 
in diameter. In smaller arterioles (capillaries) in the 6 µm range, WSS values above 10 
Pa can occur owing to non-regulatory properties of mesenteric arterioles103. These kinds 
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of local variations, coupled with realistic flow conditions (Table 1.4) must be 
incorporated into the design of artificial vascular networks in order to ensure that 
physiological conditions are reproduced. 
 
 
Table 1.3.Summary of literature reporting construction of branched microvascular 
networks. 
(Publications from the same laboratory are grouped together) 
 
Channel 
cross-
section 
Channel size 
range Micromachining method 
Based on 
Murray’s 
law? 
Spatial 
geometry Reference 
square 35 µm-5 mm lithography and etching followed by 
soft lithography No 2D 
1, 2, 34, 
35, 44, 45
 
rectangular 1.197 mm soft lithography No 2D 51
 
square, 
rectangular, 
or 
trapezoid 
44.2-250 µm simulation Yes 2D 55, 102
 
rectangular 125-660 µm laser ablation followed by chemical 
wet etching Yes 2D 
54
 
rectangular > 50 µm simulation No 2D 104
 
rectangular 100 µm-5 mm soft lithography No 2D 41
 
rectangular 20 µm-2.73 
mm 
micromachining of stainless steel 
mold, then soft lithography to cast in 
PDMS 
Yes 2D 49, 50
 
circular 80-190 µm electroplating of silicon master mold, then micro-patterning No 2D 
52
 
rectangular 40-60 µm hydrogel constructs cast from PDMS 
mold No 2D 
59
 
semi-
circular 40-120 µm wet etching Yes 2D 
42
 
rectangular 20-60 µm electroforming No 2D 37
 
circular 60-120 µm photoresist based molding and bonding No 2D 
39
 
semi-
circular 50 µm-1 mm 
laser ablation followed by chemical 
wet etching Yes 2D 
56
 
rectangular 90-600 µm laser ablation followed by chemical 
wet etching Yes 2D 
57
 
rectangular 6-50 µm soft lithography with sacrificial 
element No 2D 
43
 
rectangular 35 µm-5 mm soft lithography Yes 3D 64
 
circular 100-500 µm direct-write assembly Yes 3D 68
 
circular 200-600 µm direct-write assembly No 3D 65
 
circular 10 µm-1 mm electrostatic discharge Yes 3D 81
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Table 1.4. Characteristic flow properties in blood vessels under human 
physiological conditions105. 
 
 Artery Arteriole capillary Venule Vein 
Diameter (µm) 
 
4,000 30 6 20 5,000 
Average flow 
rate (mL/s) 1.3 4 x 10
-6
 8 x 10-9 9 x 10-7 1.0 
Mean pressure 
(mm Hg) 90 60 25 15 12 
 
 
1.2.5 Engineering meets biology: toward tissue engineering and bio-MEMS applications 
Construction of microvascular networks, while important, is only one piece of a 
much broader puzzle that must be solved in order to artificially manufacture complex 
tissues. These insights have been developed through extensive studies dating back to 
Weinberg and Bell’s pioneering demonstration of the first in vivo tissue-engineered 
blood vessels in 1986, cultured from a combination of bovine endothelial cells, smooth 
muscle cells, and fibroblasts106. Through these efforts, it is now generally appreciated 
that organ-sized artificial tissues require (1) an embedded vascular network to sustain 
transport of nutrients and waste, (2) a three dimensional matrix to support cell seeding 
and culture, and (3) incorporation of appropriate cell types into the construct. 
 The range of cell types that need to be incorporated into functional tissues is 
illustrated by considering the case of capillaries, the most abundant blood vessels, 
consisting of endothelial cells (ECs) surrounded by basement membrane (composed of 
sheet-like depositions of extracellular matrix (ECM) material) and a sparse layer of 
pericytes (a type of perivascular cell found in small vessels) embedded within the EC 
basement membrane (Fig. 1.3a). 
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The main function of capillaries is to exchange the nutrients and waste between 
blood and tissue cells by utilizing their specific wall geometry and large contact surface. 
Precapillary arterioles are completely surrounded with vascular smooth muscle cells 
(SMCs) and their own basement membrane are formed associated with the 
circumferentially arranged, closely packed, and tightly endothelium. By gradually 
coverage of mural cells on capillaries, arterioles and venules are eventually formed. 
More complex structures can also include fibroblasts, precursor cells able to synthesize 
ECM material107.  
The role of vascularization can now be appreciated in the context of a general 
strategy to construct organ-sized artificial tissues in vitro. Ordinarily, the process of 
vasculogenesis begins to unfold upon cell seeding when the ECM environment coupled 
with hypoxia (low oxygen) experienced by the cells stimulates endogenous release of 
angiogenic growth factors responsible for growth of new blood vessels. Unfortunately, 
this spontaneous vasculaturization process occurs too slowly to supply the seeded cells 
with adequate oxygen and nutrients during the time needed for a mature network to 
form108. Furthermore, it is not yet fully understood how to direct the process so that well-
defined interconnected branched networks are produced. These obstacles can be 
overcome by incorporating embedded 3D vasculature within the scaffold to both provide 
transport of nutrients and waste throughout the cell-seeded scaffold, and act as a 
template for construction of artificial vasculature by seeding the interior of the 
microchannels with endothelial cells. These embedded networks should incorporate a 
branched architecture containing small arteries (1 – 2 mm diameter) leading into an 
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arteriolar network (100 – 1000 µm diameter), and terminating in capillary-like vascular 
bed (10 – 15 µm diameter). This network should in turn be surrounded by a matrix that 
functions as a reservoir to deliver growth factors (e.g. vascular endothelial growth factor 
(VEGF)), and a scaffold that serves as a temporary  ECM (Fig. 1.3b; in tissue 
engineering applications, ECM materials are generally classified into two groups: (1) 
natural biodegradable polymers that are inherently biodegradable, non-immunogenic and 
biocompatible, and (2) synthetic biodegradable polymers with controllable mechanical 
properties and crosslinkable functional groups). The resulting scaffold can then be 
seeded with appropriate cell types (e.g., adult stem cells derived from the patient) whose 
differentiation could be orchestrated to produce mature blood vessels and ultimately 
functional tissue. 
 
1.3 Isolation of Circulating Tumor Cells 
There is currently a critical need for advanced filtration methods adaptable for 
separation of cells and cell-sized components from blood samples, specifically offering 
the capability to rapidly process large sample volumes (> mL/min flow rates). One 
example of this need can be found in efforts to develop technologies to enable rapid 
separation of blood components (red blood cells, platelets, plasma) in a portable format. 
Current blood bank procedures generally involve tedious and labor intensive manual 
steps combined with bulky centrifugation-based instruments that are typically single 
component separators, are the size of an ice chest, and can weigh as much as 30 – 60 lbs. 
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Collection of a standard blood unit can be performed in 20 minutes, but a blood 
bank laboratory is required for processing the components. Microfluidic technologies 
provide a natural platform to address these challenges, but these efforts have yet to 
advance past the proof of concept stage to show that it is possible to rapidly and reliably 
deliver blood components that meet the American Association of Blood Bank standards 
(i.e., low hemolysis of red blood cells, high percent of purity of each component, normal 
platelet function parameters, sterility, etc). 
Another key area where high-throughput separation of blood cell-sized 
components is important is in analysis of disease biomarkers relevant to cancer. In 2010, 
approximately 1.53 million Americans were diagnosed with cancer and about 570,000 
died of the disease. An estimated $263.8 billion will be spent on health care costs for 
cancer according to American Cancer Society and National Cancer Institute. But despite 
decades of research, the 5-year survival rates of cancer patients are still increasing (50% 
in 1975 to 68% in 2007). Circulating tumor cells (CTCs) refer to a class of epithelial 
cells that are released either from a primary tumor or its metastases and are subsequently 
transported throughout the peripheral blood circulatory system. CTCs have emerged as 
an area of intense research interest because of their potential to play an important role in 
cancer diagnostics (i.e., to provide early detection of metastasis) and early detection109, 
110
. Isolation of CTCs, however, poses daunting technical challenges because their 
occurrence in the bloodstream is extremely rare (of order 1 in 106 to 109 blood cells)111. 
Thus, availability of a convenient platform to monitor CTC levels (i.e., spreading of 
cancer cells from organ to organ through blood stream) would provide a new and 
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powerful method to assess the efficacy of cancer treatments so that personalized “on the 
fly” adjustments could be made during the course of therapy. 
 
 
 
 
 
 
 
 
Figure 1.3.Cellular composition of blood vessels. (a) The walls of larger vessels 
consist of three major cellular layers: endothelial cells, smooth muscle cells surrounded 
by basement membrane, and fibroblasts incorporated with extracellular matrix. (b) 
Artificial ECM materials can be broadly classified into natural and synthetic polymers. 
Mass transport between cells and the nutrient blood flow source is conducted within the 
ECM, but cells can survive by diffusion alone only if they are located within about 150 – 
200 µm of a vascular element. 
 23 
 
1.3.1 Current methods 
Current methods for CTC analysis suffer from a number of drawbacks that have 
prevented their use as a routine diagnostic tool (Table 1.5). Traditional isolation and 
enrichment methods involve density gradient centrifugation. However, the density 
difference between CTCs and other blood cells is very small, resulting in the need to 
perform additional immunostaining steps. The stained samples must be examined by a 
trained pathologist, introducing a tedious and time consuming manual process.  
Maximum CTC recovery rates are also fairly low (~70%). Immunomagnetic separation 
methods have also been employed for CTC isolation. Here, antibody functionalized 
magnetic beads are used to capture CTCs, after which they can be isolated and enriched. 
Capture efficiencies are generally improved over centrifugation-based approaches, but 
these methods are costly and limited due to the need to supply antibodies specific to the 
desired target. Membrane-based methods have also been employed to separate CTCs 
based on their size difference versus other blood cells (~15-20 µm versus 10 µm or less 
for other blood cells). But success of these methods critically depends on obtaining 
membranes with near-monodisperse pore sizes in the correct range. The membranes are 
also mechanically fragile and subject to clogging, limiting the flow rates that can be 
applied. 
  
 24 
 
Table 1.5.Overview of existing CTC enrichment methods. 
 
CTC 
enrichme
nt method 
Ref System Sample 
vol. (ml) 
CTC 
recovery Flow rate 
Analysis 
time Drawbacks 
Centrifug
ation 
112
 
Oncoquick® 10-30 25-70%  40 min Additional 
sample prep and 
bench work 
needed 
 
113
 
Oncoquick® 15-35 62-75%  45 min 
 
112
 
Ficoll 10 1-2%  30 min 
Immuno-
magnetic 
separation 
114
 
EPCAM-coated 
ferrofluid 10-20 75-100%  ~ 1 h 
Expensive, 
additional sample 
prep and bench 
work needed 
 
115-
117
 
MACS 7.5-10 83 %  2 h 
 
118
 
CellSearch® 7.5 >1/7.5 
mL  
40 
min/300 
µl 
Immuno-
selection 
119
 
Antibody coated 
microposts 2.7 65-80 % 1-2 mL/h 1-2 h 
Too slow to 
process large 
volumes for 
detection at low 
concentrations 
 
120
 
Antibody coated 
microchannel > 1 
10-250 / 
mL  ~ 35 min 
Dielectro-
phoresis 
121
 
Dielectro-
phoretic flow 
fractionation 
0.25- 4.5 90% 1.5 mL/min 20 min Special ionic buffer conditions 
Size-based 
separation 
122-
124
 
ISET 10 >1/10 mL  10 min 
Cell 
concentration 
must be diluted 
to avoid clogging, 
various 
additional sample 
preparation steps 
needed 
 
125
 
Pool-dam   0.1 mL/min  
 
126
 
Membrane filter 9 0.2-5.7 / 
mL  2 min 
 
127
 
Membrane filter 1   10 min 
 
128
 
Isolation wells 1.7 80% 0.7 mL/h 2.5 h 
 
129
 
Micropost array   0.3 mL/min  
 
130
 
Micropost array   1 mL/h  
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These challenges have motivated interest in exploring microfluidic-based 
approaches for CTC isolation and enrichment (Fig. 1.4). Many of these methods are 
based on constructing micromachined filtration structures that act either alone to provide 
size-selective isolation or in combination with functionalized antibodies to provide 
affinity capture. Although previous work in this area has demonstrated the potential of 
these microdevices to provide enhancements in CTC analysis131, they still suffer from 
limitations inherent to the filtration-based design. Most notably, the achievable flow 
rates are typically very small due to the large pressures that must be applied to force the 
cell suspension to flow through the tiny pore networks present. Consequently, the cell 
suspensions usually must be diluted prior to analysis (making it necessary to process 
even greater volumes due to the rare nature of CTCs), and the large internal shear 
stresses prevent recovery of viable cells unless extremely low flow rates are used 
(further increasing the analysis time)131. These problems with existing methods point to a 
need for development of filtration approaches capable of isolating CTCs (1) at high flow 
rates, (2) with no clogging and (3) preserving cell viability. 
 
1.3.2 Size-based filtration 
Size-based filtration is a nearly ideal candidate to separate and enrich CTCs 
which are well-known to be larger in size than normal leukocytes and erythrocytes132-135. 
These size differences can be very dramatic in many clinically relevant examples. For 
example, Menget al. found that from those patients’ blood diagnosis with breast cancer 
the mean diameter of tumor cells ranges from ~30-34 µm134. A further relevant example 
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is found in the work of Vonaet al. who used size-based isolation to obtain epithelial 
tumor cells (ISET) from patients with liver cancer, and found characteristic sizes to be in 
the range of ~40-42 µm136. 
 
 
 
 
 
Figure 1.4. Overview of previous microfluidic CTC filtration designs. (a) “pool-
dam” structures based on alternating deep and narrow channel segments (reproduced 
with permission from reference125), (b) arrays of antibody functionalized posts 
(reproduced with permission from reference119), and (c) etched porous membranes 
(reproduced with permission from reference127). All of these are restricted to low flow 
rate operation and permit only limited recovery of viable cells.  
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Another important point is that metastatic tumor cells do not individually shed 
from primary tumors as signalmesenchymal-like cells and invade through nearby blood 
or lymph vessel walls. In fact, these malignant tumor cells may also invade surrounding 
normal tissues in the form of  cell clusters or multicellular aggregates in a process known 
as ‘‘cohort’’ or ‘‘collective’’ migration137. Recent studies investigated that these tumor 
cell clusters, much larger in size than any other blood components, can attach to and 
rupture vessel walls of arterioles and capillaries andprovidefurther advantages for tumor 
cell survival, proliferation, and formation of small tumor known as micrometastasesin 
distant organs138, 139. Thus, it is generally accepted that the presence of circulating tumor 
cell clusters, easily distinguishable by filtration methods, can be viewed as a diagnosis 
marker of highly metastatic potential138-142 
The “pool-dam” structuresshown in Fig. 1.4a125operate in a specific design (i.e., 
by imposing a physical obstacle that restricts the flow of larger sized components in the 
fluid), but placement of the barriers perpendicular to the flow direction makes the pool-
dam arrangement highly susceptible to clogging and introduces large pressure drops that 
limit achievable flow rates (especially if recovery of viable cells is desired). 
Nevertheless, successful separation of SPA-C-1 CTCs from whole blood samples was 
demonstrated using the pool-dam configuration, thereby validating the underlying 
principle of the physical separation mechanism. Taken together, these considerations 
suggest that a size-based filtration approach can provide a highly effective tool for 
isolation and enrichment of CTCs. 
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1.3.3 Compared to conventional affinity-based methods 
To further illustrate the benefits of a size-based separation approach, the 
CellSearch® assay based on immuno-magnetic antibody enrichment, the first CTC-
based system to receive FDA approval for monitoring patients with metastatic breast, 
colorectal, and prostate cancers is compared. Although the assay is effective, results can 
be inconsistent due to the inherent need to rely solely on affinity interactions. In the case 
of breast cancer, for example, the frequency of Ep-CAM expression can vary over a 
fairly wide range (i.e., from ~35 to 100%)143-146. It has also proven challenging to 
identify antibodies that are highly specific to CTCs (i.e.,epithelial antigens expressed not 
only by all types of invasive tumor cells but also expressed by leukocytes or by other 
circulating non-tumor cells)109. Moreover, the majority of antibodies currently employed 
are limited to selection of cancer cells expressing epithelial antigens. Consequently, anti-
cytokeratin antibodyhas been reported to show specific and non-specificbinding to 
macrophages, plasma cells and nucleated hematopoietic cell precursors to generate a 
false-positive result147, 148. Finally, even if highly specific antibodies are identified, the 
affinity-based approach inherently limits the ability to detect other circulating tumor 
cells or “rare cells” (e.g., trophoblastic, endothelial progenitor149 and stem cells) for 
which specific antibodies have not yet been developed. The significance of these 
drawbacks is evident by the fact that the American Society of Clinical Oncology does 
not currently recommend the use of CTC measurements for diagnostic or treatment 
decision making150. These limitations offer a compelling argument against the 
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conventional affinity-based approach for CTC analysis, and point to the need for more 
general (i.e., size-based) isolation/enrichment methods. 
 
1.4 Organization of the Dissertation 
In Chapter II, the experimental procedures are provided that show how to 
fabricate microvascular networks in different types of materials and construct complex 
topologies via a novel approach. In Chapter III, the fabrication process of tree-like 
microvascular networks is reported along with an analysis of their branching 
characteristics. In Chapter IV, the improved fabrication methods are demonstrated and 
show the abilities to mimic the similar geometry of a natural microvascular network. In 
Chapter V, the construction methods and mechanism of enzymatic micro- and nano- 
fabrication are described. In Chapter VI, the mechanism and application of 
membraneless microfluidic filter are discussed. Finally, the conclusions of my 
dissertation are summarized in Chapter VII. 
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CHAPTER II 
EXPERIMENTAL PROCEDURES  
 
2.1 Block Sample Preparation 
Polished acrylic rectangular blocks (1x3x3 inch) and cylindrical rods (1.5 inch 
dia., 4.5 inch long) were purchased from Trio Display (San Diego, CA). Polished blocks 
are desirable when constructing discharge networks using the grounded contact method 
because they reduce nucleation of unwanted spontaneous discharges that may occur due 
to surface imperfections. Rectangular blocks of poly(lactic acid) were thermally molded 
from pelletized resin (NatureWorks grade 3051; Jamplast Inc., Ellisville, MO). Pellets 
were loaded into molds constructed from poly(dimethyl siloxane) and heated to 180 °C 
under vacuum for 2 h, after which the vacuum was released and heating continued for an 
additional hour. The mold was then removed from the oven and cooled at room 
temperature so that the PLA blocks (1.5x5x8 cm) could be easily released. 
 
2.2 Electrostatic Discharge 
Experiments were performed at the National Center for Electron Beam Research 
at Texas A&M University. This system employs a 15 kW linear accelerator to produce a 
single 10 MeV electron beam directed upward from below the sample. The energy of the 
incident beam was attenuated using three sheets of 5 mm thick high-density 
polyethylene (HDPE) to achieve the target dose at the desired depth inside the substrate. 
An estimate of the maximum penetration depth was obtained using CSDA range data at 
 31 
 
10 MeV provided in the NIST ESTAR Database of Stopping Powers and Ranges for 
Electrons (physics.nist.gov/PhysRefData/Star/Text/ ESTAR.html). Applying these 
parameters (RCSDA,PMMA = 5.158 g cm–2, ρPMMA = 1.19 g cm–3; RCSDA,HDPE = 4.833 g cm–2, 
ρHDPE = 0.957 g cm–3) yields average penetration depths of 4.33 and 4.06 cm in PMMA 
and HDPE respectively. For light particles like electrons, the CSDA range represents a 
maximum upper-limit value of the actual penetration depth (experimental data place the 
peak dose at RPMMA ~ 2.8 – 3 g cm–2)151. that is useful to determine the attenuation 
needed to maximize the implanted charge. The substrate and attenuating sheets were 
mounted on a cardboard carrier tray and transported though the electron beam by a 
conveyor at a speed of 10 ft min–1. Microchannel networks formed by spontaneous 
discharge became embedded inside the substrate immediately upon exposure to the beam 
(holes of approximately 1 mm diameter were drilled to a depth of about 1 cm, tapering to 
a point near the bottom of the hole; we did not observe a strong effect of hole size on the 
features of the resulting network, but this was not systematically investigated). In the 
grounded contact method, irradiated substrates were discharged using a hammer to strike 
the surface with a sharp-tipped metal tool (e.g., a nail or needle) connected to a grounded 
cable. 
 
2.3 Flow Analysis 
Interconnectivity and flow within the vascular networks were quantified by 
injecting an aqueous solution of blue food dye using a syringe pump at flow rate of 0.1 
µl min–1. Volumetric imaging of the microvascular networks was performed using a 
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Leica TCS SP5 Confocal microscope (scan speed 400 Hz) to scan blocks injected with 
Rhodamine B dye (Sigma-Aldrich). Image stack data were then assembled into 3D 
reconstructions. Instrument limitations (e.g., acquisition times of several hours) 
restricted the allowable imaging volume to a small subregion of the overall network. 
 
2.4 Image Analysis 
Branching characteristics were quantified by using photographic images of the 
networks acquired along the midplane of each block (Fig. 2.1) as a basis to render digital 
reconstructions using Neuromantic software (www.rdg.ac.uk/neuromantic/), after which 
the software package L-Measure (cng.gmu.edu:8080/Lm/pdfs/lmhomepg.jsp) was used 
to extract quantitative parameters. Fractal dimension calculations were performed using 
Fractalyse analysis software (fractalyse.org/en-home.html). All software packages are 
freely available. 
 
2.5 PLA Substrate Preparation 
Smooth planar substrates were obtained by placing pelletized PLA resin (MW = 
1.04 x 105 g/mol, NatureWorks, grade 3051D; Jamplast Inc.) directly onto glass 
microscope slides. A silane pre-treatment was applied to enable easy release of the PLA 
film by exposing the slides to tridecafluoro-1,1,2,2-tetrahydrooctyltrichlorosilane vapor 
(SIT8174.0; Gelest Inc.) inside a dessicator for at least 2 h at room temperature. The 
glass slides containing the PLA pellets were heated to 180 °C under vacuum for 1 h, 
followed by an additional 1 h of heating after the vacuum was released. The slides were 
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then cooled at room temperature for 1 h, after which the PLA film could be easily peeled 
away.  
 
 
 
 
 
 
 
 
Figure 2.1.Illustration of image acquisition. Quantitative analysis of the network 
morphology presented in Fig. 3.5 and Table 3.1. 2D projections of the discharge network 
were collected by aligning the focal plane of the camera approximately along the 
midplane of the block. These images were then used to reconstruct the network using the 
software described in the paper. 
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2.6 Patterned PLA Substrate Preparation 
Reversepatterns were photolithographically defined using a mask printed on 
transparency film at 65,024 dpi. The resulting photoresist structures were then used as 
master molds to replicate the reverse microchannel patterns in PDMS (Sylgard 184; 
Dow Corning) prepared using a 10:1 degassed mixture of prepolymer and curing agent. 
After curing for 2 h at 80 °C, the cooled PDMS slab was peeled from the master mold as 
a soft elastomer template. This PDMS mold containing reverse microchannel patterns 
was rinsed with 2-propanol (Fisher Scientific), dried in a stream of compressed air. 
Microchannel patterned PLA plate can be constructed by directly placing pelletized PLA 
resin (MW = 1.04 x 105 g/mol, NatureWorks, grade 3051D; Jamplast Inc.) onto PDMS 
mold and heating to 180 °C for 1 h under vacuum, followed by another 1 h at 
atmospheric pressure and then cooled at room temperature for 1 h(Fig. 2.2). After 
peeling from PDMS mold, the fluidic access ports on PLA microchannel were drilled 
with a 1/32 inch bit. Smooth planar substrates were obtained by placing pelletized PLA 
resin directly onto glass microscope slides. A silane pre-treatment was applied to enable 
easy release of the PLA film by exposing the slides to tridecafluoro-1,1,2,2-
tetrahydrooctyltrichlorosilane vapor (SIT8174.0; Gelest Inc.) inside a dessicator for at 
least 2 h at room temperature. The glass slides containing the PLA pellets were heated to 
180 °C under vacuum for 1 h, followed by an additional 1 h of heating after the vacuum 
was released. The slides were then cooled at room temperature for 1 h, after which the 
PLA film could be easily peeled away. Both the microchannel patterned and flat PLA 
plates were rinsed with 2-propanol followed by DI water and dried with compressed air. 
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Enclosed microchannels were fabricated by directly placing the patterned PLA replica 
on the flat PLA plate and heated at 80 °C for 20 min. Tygon tubing (0.03 inch O.D.) was 
inserted into the access ports and sealed with epoxy glue to obtain interconnect fluidic 
channels. 
 
 
 
 
 
 
 
Figure 2.2. Schematic of fabrication enclosed PLA microhannels with fluidic access 
ports (see also in Fig. 6.7). (a) A PDMS mold containing reverse patterns was obtained 
from demolding of etched PLA or patterned SU-8 silicon wafer. This mold was punched 
with a blunt needle and inserted with a pillar shape PDMS. (b) After melting process, 
patterned PLA plate was peeled from PDMS mold. (c) Enclosed microchannels can be 
fabricated by thermal bonding with another flat PLA substrate. (d) PLA device 
embedded with patterned microchannel was constructed by inserting Tygon tubing and 
sealing with epoxy glue. 
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2.7 Air Deformation Process 
The enclosed PLA substrate embedded with microchannels and connected with 
tygon tubing was coupled with pneumatic drive system consisting of compressed air, 
pressure regulator and pressure gauge to control and monitor the desire pressure. 
Connected PLA substrate then can be stored in temperature controllable vacuum oven 
(VWR 1415M, West Chester, PA) for desire polymer softening temperature condition. 
The process was stopped by closing pressure valve and removing the PLA substrate 
from the oven to cool down at room temperature. The contraction effect of molten PLA 
after stopping process can be ignored because of low mold shrinkage value of PLA 
(0.004 in/in, provided by NatureWorks® Co.). 
 
2.8 Computational Fluid Dynamics (CFD) Analysis 
2.8.1 COMSOL Multiphysics 
A 3D computational model was formulated using COMSOL Multiphysics 
(version 4.0a, COMSOL, Inc.)  The laminar flow and viscoelastic material models were 
selected from COMOSL’s model library to simulate geometry change of channel, and 
two-dimensional convection-diffusion mode was selected to numerically evaluate mass 
transport model. The computational domain was discretized into a mesh of quadrilateral 
elements.Properties of water at 37 °C (ρ = 993.36 kg/m3, µ = 6.9 x 10-4Pa·s) were used 
to represent all solutions (proteinase K, buffer, BSA). Diffusion coefficients for 
proteinase K, BSA, and PK-BSA complex were estimated to be 1.22 x 10-6, 9.25 x 10-7, 
and 8.2 x 10-7 cm2/s, respectively based on their molecular weight (T = 37 °C)152. 
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2.8.2 STAR-CCM+ (CD-adapco) 
A 3D computational model was formulated using STAR-CCM+ (CD-adapco) 
meshed using a nonuniform grid containing 212,992 cells. Water was used as the fluid 
with properties at room temperature. A flow rate of 1 mL/min was imposed on each side 
of the centerline barrier as the inlet boundary condition, with a flow-split boundary 
condition at the outlet. Particle transport was assessed by simulated injection of 3 µm 
diameter beads randomly distributed throughout the cross-section along the inner flow 
path. Lagrangian tracking was applied to dynamically map the particle positions as they 
traveled through the microchannel. A Schiller-Naumann drag coefficient was applied to 
calculate the drag force on the particles, and elastic wall interactions were imposed.  
 
2.9 PLA Based MicrovascularNetwork Scaffold 
(1) Seven layers of patterned branched network. Seven pieces of patterned 
PLA microchannel and one piece of flat PLA plates were rinsed with 2-propanol 
followed by DI water and dried with compressed air. All layers of PLA sheet were 
thermally bonded at 80 °C for 20 min to form an enclosed flow network at the same 
time. Tygon tubing (0.03 inch O.D.) was inserted into the access ports and sealed with 
epoxy glue to obtain interconnected fluidic channels. (2) Electrostatic discharged 
vascular network. Rectangular blocks of PLA were thermally molded from pelletized 
resin by using the substrate preparation method above.Experiments were performed at 
the National Center for Electron Beam Research at TexasA&M University. The 
substrate and 1.5 cm of HDPE (high-density polyethylene) attenuating sheets were 
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mounted on a cardboard carrier tray and transported though the 10 MeV electron beam 
by a conveyor at a speed of 10 ft/min. Microchannel networks formed by spontaneous 
discharge became embedded inside the substrate immediately upon exposure to the beam 
(holes of 1 mm diameter were drilled to a depth of about 1 cm, tapering to a point near 
the bottom of the hole81. (3) Porogen embedded scaffold. The pelletized PLA resins (2 
g) were dissolved in chloroform solvent (10 mL) and mixed with 90 % w/w sieved 
sodium chloride (250-420 µm with #40 and #60 sieves from McMaster-Carr) as porogen 
to yield moldable slurry mixture. The mixture then was placed and compacted into 
hollow Teflon mold (5 mm in diameter and 5 mm in height) and air dried in fume hood 
for overnight. The solidified polymer/porogen disc-like scaffolds were removed from 
mold and soaked with 2-propanol for 2 h to replace solvent following by air dried again 
for overnight to completely vaporized remain solvent. The scaffolds were stored in a 
vacuum desiccator for later use. PLA patches contained high concentration porogen 
were fabricated by directly placing polymer/porogen disc-like scaffolds into melted PLA 
and cooled down at room temperature. Molded PLA patches were electrostatic 
discharged by using the method mentioned above to create vascular branched networks.  
 
2.10 Cell Culture in PLA Channel 
Circular PLA microchannels were coated with 25 µg/mL of fibronectin (BD 
Biosciences) followed by incubating in 37°C, 5% CO2 incubator for 1 h to facilitate the 
cell attachment. The channels were then rinsed with DMEM medium (SAFC 
Biosciences) contained 10% FBS (Thermo Science) and 1% penicillin-streptomycin).  
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Bovine Aortic Endothelial Cells (BAECs) were prepared at 5 x 106 cells/mL medium for 
500 µm channel or 2 x107 cells/mL medium for 100 µm and branched channel. After 
inoculating cell suspension into the channel, the microchannels were put into the 
incubator for 2 h to allow cells attach well. The devices were refreshed with medium and 
then reseed with cells, rotated by 120° and again placed into the incubator for another 2 
h. This step was repeated one or two more times to let cell confluence in the circular 
channel. After completion of seeding procedure, attached cells were stain with 25 µM of 
CellTracker Green CMFDA (Invitrogen) and incubated for 1 h to trace live cells. For 
long term cell culture, the microchannels within PLA substrate were connected with a 
computer controlled micropump system and flushed with continuous circulating medium 
at flow rate of 0.5 µL/min. Cell viability was monitored and imaged under fluorescence 
microscopy (Axiovert 200M, Carl Zeiss MicroImaging, Inc.). 
 
2.11 Microfluidic Etching Template 
Microchannels were fabricated in poly(dimethyl siloxane) (PDMS) using soft 
lithography36. Briefly, master molds were constructed using SU-8 2050 photoresist 
(Microchem) applied to a 35 mm silicon wafer by spin coating at 3,200 rpm for 60 s, 
yielding a 50 µm thick layer. Patterns were photolithographically defined using a mask 
printed on transparency film at 20,320 dpi. The resulting photoresist structures were then 
used as master molds to replicate the microchannel patterns in PDMS (Sylgard 184; 
Dow Corning) prepared using a 10:1 degassed mixture of prepolymer and curing agent. 
After curing for 2 h at 80 °C, the cooled PDMS slab was peeled from the master mold 
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and fluidic access ports were punched with a 22 gauge blunt-end needle. The 
microchannels were rinsed with 2-propanol (Fisher Scientific), dried in a stream of 
compressed air, and directly adhered to the flat surface of a PLA substrate to produce 
enclosed channel networks. Tygon tubing (0.03 inch O.D.; Small parts Inc.) was inserted 
into the access ports, and the entire assembly was clamped between two acrylic sheets to 
ensure a tight seal. 
 
2.12 Enzymatic Etching 
Aqueous solutions of proteinase K (MW = 28.9 kDa; BP1700, Fisher Scientific) 
and BSA (MW = 66.4 kDa; A2153, Sigma-Aldrich) were prepared in 30 mMTris-HCl 
buffer (pH 8.0, BP1758; Fisher Scientific). An etchant concentration of [PK] = 6.92 µM 
(0.2 mg/mL) was used in most experiments. Prior to etching, the PDMS microfluidic 
template was thoroughly rinsed with DI water. A syringe pump (PHD 2000; Harvard 
Apparatus) was connected, and the entire assembly was placed inside an incubator while 
the etching solutions (enzyme, BSA, buffer) were continuously pumped though the 
network at 37 °C. After etching was completed, the PDMS template was removed from 
the PLA substrate and the resulting patterns were washed using 2-propanol following by 
DI water to stop the enzymatic reaction. The etched channel depths were measured using 
a Dektak 3 stylus profilometer (Veeco Instruments). Surface topologies were imaged 
using a JEOL JSM-6400 scanning electron microscope, post processed with NanoScope 
Analysis software (v1.4; Bruker Corp). 
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Nanochannels were etched using a microchannel with 3 inlets to co-inject a 
central stream of PK with BSA solution on each side (2 µL/min each stream) into a 
tapered microchannel for 3 h at room temperature (25 °C). The BSA sheath flows 
focused the PK stream to confine etching within a ~ 4 µm wide zone in the narrow 
constriction region of the microfluidic template. Nanochannel topologies were 
characterized using a Nanoscope III atomic force microscope (Digital Instruments; Santa 
Barbara, CA) and post processed with SPIP software (Image Metrology, Denmark). 
 
2.13 Flow Visualization 
Images of the flow field inside the microchannels were obtained using a Zeiss 
Axiovert 200M fluorescence microscope. Brightfield images of co-injected food dye 
streams were used to visualize the interface under different flow conditions. Diffusive 
transport of BSA was observed using FITC-BSA (A9771; Sigma-Aldrich). Images were 
acquired using Zeiss AxioVision Software version 4.8 with a FITC filter set. 
 
2.14 Membraneless Filtration Device 
The etching process described above was first applied to construct the 
microchannel geometry in PLA, after which the etched PLA was used as a template to 
construct a PDMS mold. The fluidic access ports on PDMS mold were punched with a 
20 gauge blunt-end needle and inserted with a pillar shape PDMS (1/32 inch in 
diameter) fixed with PDMS mixture. This PDMS mold, containing a reverse imprint of 
the etched pattern, was then used repeatedly to produce additional microchannels in PLA 
 42 
 
(Fig. 2.3). Enclosed microchannels were then constructed by thermally bonding the PLA 
replica to a flat PLA substrate molded using glass slides as described above. Both the 
microchannel and flat substrate were rinsed with 2-propanol followed by DI water and 
dried with compressed air. The PLA replica was directly placed on the flat PLA 
substrate and heated at 80 °C for 20 min. Tygon tubing (0.03 inch O.D.) was inserted 
into the access ports and sealed with epoxy glue. Aqueous suspensions of fluorescent 
polystyrene latex microbeads (3 and 10 µm diameter; Catalog numbers 17155 and 
17156; Polysciences, Inc.) were diluted to 1.68 x 106 and 4.55 x 104 particles/mL, 
respectively and injected into the inner inlet of the filtration device while water was 
infused through the outer inlet. The separated microbeads were observed using an 
Olympus SZX12 stereoscope with fluorescence illuminator and CCD-300 camera 
(DAGE-MTI). 
 
2.15 Blood Cell Separations 
Human prostate cancer cell line PC3 obtained from ATCC (Manassas, VA) was 
maintained in RPMI 1640 medium (Sigma-Aldrich) supplemented with 10 % fetal 
bovine serum (Hyclone), 100 U/mL penicillin, and 100 µg/mL streptomycin (Sigma-
Aldrich) at 37°C under a humidified 5% CO2. PC3 cells were then stained with 
CellTracker Red CMTPX (Invitrogen) and spiked into fresh human blood (K2 EDTA 
anticoagulant) obtained from Bioreclamation Inc. The ratio of blood cells and PC3 cells 
were adjusted by addition of phosphate buffered saline solution (Fisher Scientific) to 
achieve equal amount of WBCs and PC3 cells. Cell counts were obtained using a 
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Multisizer 3 Coulter counter (Beckman Coulter). Erythrocytes were lysed with Zap-
oglobin II lytic reagent (Beckman Coulter) for determination of leukocyte and cancer 
cell counts. Pure PC3 cells were also counted as a control to determine their size 
distribution profile. Cells numbers are expressed with respect to the total collected 
sample volume. 
 
 
 
 
 
Figure 2.3.Reproducible hot-molding process.(a) A replica mold is made by casting 
PDMS elastomer directly onto etched PLA channels. The curing temperature of PDMS 
should not exceed the glass transition temperature of PLA (60 – 65 °C) to avoid 
deformation of the etched structures. After curing for 2 h at 50 °C, the PLA substrate can 
be peeled from the mold leaving the reverse pattern imprinted in PDMS. The solidified 
PDMS is then further cured for 1 h at 80 °C. The original etched PLA substrate can be 
used to make multiple PDMS molds. Once the inverse pattern is replicated in PDMS, 
microchannels are constructed by placing PLA resin in the mold and heating to 180 °C 
for 1 h under vacuum, followed by another 1 h at atmospheric pressure and by cooling at 
room temperature for 1 h. (b)Profilometry data show that the molded microchannels 
identically replicate features of the original etched substrate. 
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2.16 Imprinting of Crystalline Morphologies 
PLA substrates with different crystalline morphologies were obtained by placing 
pelletized resin directly onto planar PDMS slabs that could be easily separated after 
molding. The pellets were melted at 180 °C under vacuum for 1 h, followed by an 
additional 1 h of heating after the vacuum was released. The PLA was then annealed 
under different conditions (e.g., 70 °C for 8 h, 80 °C for 1h, 120 °C for 1h), removed 
from the oven, and cooled to room temperature (25 °C) in the ambient environment. The 
crystalline morphologies were observed with an optical microscope (Zeiss Axiovert 
200M). 
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CHAPTER III 
RAPID FABRICATION OF BIO-INSPIRED 3D MICROFLUIDIC 
VASCULAR NETWORKS* 
 
3.1 Introduction 
Living systems face a fundamental challenge of orchestratingexchange of 
nutrients and oxygen throughout 3D space in orderto satisfy their metabolic needs8. In 
nature, vascular networkshave evolved to elegantly address this problem by 
incorporatinghighly branched fractal-like architectures that are efficientlyspace-filling 
while minimizing the energy required to sustain transport20, 21. The ability to mimic these 
features in vitro would beimmensely beneficial in the field of tissue engineering, 
wherediffusion limitations generally restrict the maximum thickness ofconstructs to a 
few hundred microns12, 16, 153.In this chapter, we address thisneed by introducing a nearly 
instantaneous method to embedbranched 3D microvascular networks inside plastic 
materials. Inthis microfabrication process, a high level of electric charge is 
firstimplanted inside a polymer dielectric using electron beamirradiation. The 
accumulated energy is then discharged in acontrolled manner to locally vaporize and 
fracture the material,leaving behind a network of branched microchannels arranged ina 
tree-like architecture with diameters ranging from 10 µm to1mm.  
 
____________ 
*Part of the data reported in this chapter is reprinted with permission from: Rapid 
Fabrication of Bio-inspired 3D Microfluidic Vascular Networks by Huang, J.H. et 
al..Advanced Materials21, 3567-3571 (2009).©2009 by WILEY-VCH Verlag GmbH & 
Co. KGaA, Weinheim. 
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Modulating the irradiation profile and discharge locationsallows the networks’ 
morphology and interconnectivity to beprecisely tailored. Interconnected networks with 
multiple fluidicaccess points can be straightforwardly constructed, and quantificationof 
their branching characteristics reveals remarkablesimilarity to naturally occurring 
vasculature. This method can beapplied in a variety of polymers, and may help enable 
productionof organ-sized tissue scaffolds containing embedded vasculature. 
 
3.2 Limitation 
The hierarchy of length scales that comprise vascular networks(ranging from 
µm–mm in diameter) and the need for thesestructures to be widely accessible throughout 
a sizeable 3Dvolume present significant manufacturing challenges. Photolithography-
based microfabrication technology has been extensivelyexamined as a potential avenue 
to address some of theseissues34, 37, 39, 41, 48, 104, 154, 155 Here, planar micromachining is 
harnessed toproduce 2D microchannel arrays that can be stacked in alayer-by-layer 
fashion to achieve a limited degree of three dimensionality156. But assembly of large-
scale multi-tiered structures is tedious, and the inherently planar nature of the individual 
layers restricts the network’s topological complexity.More recent developments have 
enabled fully 3D flow architectures to be produced using methods including solid 
freeform fabrication, stereolithography, and direct printing42, 60, 66, 153. But these 
approaches generally involve time consuming serial processes, and the optimal range of 
feature sizes associated with each technology is often relatively narrow. These methods 
only provide a coarse approximation of microvascular structure, and no single technique 
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has proven ideal for use over the entire range of length scales associated with a whole-
tissue vascular network. Most of these processes are also challenging to scale up toward 
levels feasible for mass production157. 
 
3.3 Electrostatic Discharge 
We have developed a fabrication method that uniquelyovercomes these 
limitations, enabling branched 3D microvascularnetworks incorporating a wide range of 
microchanneldiameters to be rapidly constructed in a variety of plastic materials (Fig. 
3.1). This process harnesses electron beam irradiation to implant a high level of electric 
charge inside a substrate so that theenergy released upon discharge will be sufficiently 
intense to locally vaporize and fracture the surrounding material. In this way, networks 
of highly branched tree-like microchannels are produced that become permanently 
embedded within the substrate. The formation and growth of these electrostatic 
discharge structures (i.e., Lichtenberg figures or Lichtenberg trees) are analogous to 
lightning phenomena that occur during thunderstorms when charge accumulation within 
clouds exceeds the breakdown potential of the surrounding atmosphere158-160. 
We first explored applying this process to construct 3D vascular microchannel 
networks in acrylic plastic substrates by irradiating blocks of polished poly(methyl 
methacrylate) (PMMA) using a 10MeVelectron beam to implant a prescribed charge 
distribution (typical space charge densities are on the order of 1 µC/cm2)160, after which 
the energized blocks were discharged by one of two methods. In the first approach (Fig. 
3.1a), release of the accumulated charge was achieved by striking the irradiated block 
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with the sharp tip of a grounded electrode. The point source of electrical grounding and 
the mechanical stress associated with the physical impact of striking the block combine 
to produce an immediate and rapid energy release159. Alternatively, a defect (e.g., a 
small hole ~1mm in diameter) was intentionally introduced on the surface of the block 
prior to irradiation.Upon exposure to the electron beam this depthserved as a nucleation 
site for spontaneous discharge without the need for further physical contact (Fig.3.1b). 
In either case, the rapid and intense release of electrostatic energy instantaneously 
generated a hierarchically branched microchannel array penetrating throughout the entire 
volume of the block and originating from either the point of contact with the grounded 
electrode or the nucleationsite created on the surface (Fig. 3.1c). Networks formed using 
the grounded contact methodgenerally incorporate more tree-like architectures 
consisting of awell-defined central trunk several mm in diameter with progressively finer 
branches extending outward, while spontaneous discharge yields microchannels that are 
more randomly dispersed throughout the substrate (e.g., see photos in Fig. 3.1a and b). 
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Figure 3.1. Harnessing electrostatic discharge phenomena to rapidly construct 
branched 3D microvascular networks. (a) In the grounded contact method, electron 
beam irradiation is used to implant a high level of internal electric charge inside a 
dielectric substrate. A grounded electrode is then brought into contact with the substrate 
surface, initiating sudden energy release that locally vaporizes the surrounding material 
leaving behind a tree-like branched microchannel network. (b) In the spontaneous 
discharge method, a defect (e.g., small hole) is first created on the substrate surface prior 
to irradiation. When the internal electric charge exceeds a critical level upon exposure to 
the electron beam, the defect acts as a nucleation site for spontaneous energy release. 
The grounded contact method yields a more “tree-like” morphology while 
microchannels produced by spontaneous discharge permeate the substrate more 
uniformly. (c) Image sequence from a video recording of discharge by grounded contact 
shows that energy release is nearly instantaneous with subsequent weaker discharges 
persisting over longer timescales. All photographs depict microchannel networks in 
1x3x3 inch polished acrylic blocks. Note that all networks extend in 3D throughout the 
volume of the blocks. Scale bars, 1 cm. 
  
 50 
 
The morphology and branching characteristics of the microchannelnetworks are 
largely dictated by the magnitude and distribution of accumulated charge inside the 
substrate prior to discharge. This level of accumulation is in turn determined by an 
interplay between 1) the penetration depth (range) of the impinging electrons and 2) the 
time of exposure to the incidentbeam (dose). Penetration depth profiles inabsorbing 
media reflect the distribution ofcomplex and tortuous paths traveled by incident 
electrons, and can be inferred using a combination of experimental dose distribution 
data151 and penetration range calculations based on the continuous slowing down 
approximation (CSDA)161. The CSDA analysis predicts a maximum penetration depth 
of4.3 cm for PMMA, implying that mostelectrons would pass through the 2.54 cm thick 
acrylic blocks and yield little or no charge accumulation. Since the beam energy is fixed, 
we controlled the penetration depth by inserting polyethylene attenuators into the beam 
path to ensure that a majority of the incident electrons became implanted inside the 
PMMA blocks. Exposure dose from the continuous irradiation source was controlled by 
adjusting the speed of a conveyor that transported the blocks through the beam. We 
found that a speed of 10 ft/min (1 ft = 0.3048 m) permitted sufficient charge 
accumulation. Faster speeds resulted in weak discharges thatgenerated tiny thread-like 
microchannels whileslower speeds yielded regions where locally violent discharges 
produced large globule-like features that obscured the underlying branched network 
morphology (Fig. 3.2). Proper selection of penetration depth and irradiation dose 
enabled us to reproducibly achieve a high level of control over the microchannel 
network architectures constructedusing electrostatic discharge. 
 51 
 
a.            b. 
   
 
Figure 3.2.Microchannels with globule-like features.(a),(b) Photographs depicting 
two examples of microchannel networks implanted in 1x3x3 inch polished acrylic blocks 
using the grounded contact method (arrows denote discharge locations). In both cases a 
level of charge higher than normal was implanted inside the block prior to discharge, 
leading to locally violent energy release that produced large globule-like regions that 
obscured and interfered with the underlying branched network morphology. 
 
 
3.4 Flow Visualization  
Flow-through perfusion capabilities necessarily require interconnected networks 
possessing multiple access points for inlet and outlet streams. These architectures can be 
straightforwardly constructed using a multi-stepprocess whereby an initial discharge 
networkis first implanted using either of the methods illustrated in Fig.3.1, after which 
the substrate is re-irradiated by the electron beam one or more additional times in order 
to nucleate further discharges. These secondary spontaneously generated microchannels 
originate from nucleation sites defined by positioning one or more small holes at desired 
locations along perimeter of the block, and naturally become interconnected with the 
network already embedded inside the substrate (Fig. 3.3a). The location of each 
nucleation site and the number of irradiation/discharge cycles can be adjusted to 
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manipulate the size, morphology, and density of the resulting microchannelnetwork (Fig. 
3.3b–e). Each discharge nucleation site provides an independent access point for fluid 
injection or collection. Flow and interconnectivity can be directly observed by 
introducing tracer dye solutions using a syringe pump to permit visualization, both in 2D 
by recording images of a subset of the network occupying a specific focal plane (Fig. 
3.4a), and in 3D by usingconfocal laser scanning microscopy (Fig. 3.4b). Analysis of 
these images reveals a fractal-likemicrochannel architecture incorporating a hierarchy of 
diameters ranging from 500 µm at the ‘‘trunk’’ of the tree structure to10 µm near the tips 
of the outermost branches. Some of themicrochannels incorporate dead ends, mostly at 
the highest levels of branching (i.e., the tips of the branches), yielding anarchitecture 
analogous to a capillary bed where the smallest ducts at the ends of the network may not 
be physically interconnected but are densely arrayed to facilitate diffusive transport 
between neighboring branches. 
We also wanted to determine whether electrostatic discharge could be harnessed 
to embed branched vascular networks in biodegradable substrate materials relevant for 
tissue engineering by testing the process using thermally molded blocks of poly(lactic 
acid) (PLA). Here, we used the spontaneous discharge approach (Fig. 3.1b) to define the 
network’s point of origin by creating nucleation sites at specific surface locations (Fig. 
3.4c).We find that electrostatic discharge is robustly applicable to PLA substrates, with 
interconnected networks possessing channel diameters comparable to but within a 
slightly narrower range than those formed in the acrylic blocks (300 µm at the trunk to 
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20 µm near the tips), likely reflecting differences in dielectric properties between 
materials. 
 
 
 
Figure 3.3. Interconnected branched microvascular networks with multiple fluidic 
access points. (a) A single branched microchannel network is first constructed using 
either of the methods described in Fig. 3.1. One or more additional nucleation sites are 
then created on the surface and the block is re-irradiated to initiate further spontaneous 
discharges originating at each site. Microchannel networks created in 1x3x3 inch 
polished acrylic blocks (b-d) and a 1.5 inch dia., 4.5 inch long polished acrylic rod (e) 
become interconnected during the subsequent irradiation/discharge steps providing 
multiple locations for fluidic injection and collection. The extent of branching in the 
embedded networks are progressively increased by the additional irradiation/discharge 
cycles. Scale bars, 1 cm. 
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Figure 3.4.Branched microvascular networks embedded in acrylic and PLA 
substrates incorporate a hierarchy of microchannel diameters. (a) Injecting an 
aqueous solution of blue food dye into an interconnected microchannel array in a 1x3x3 
inch polished acrylic block with three fluidic access points enables direct visualization of 
the flow network (scale bar, 1 cm). A close-up view reveals the tree-like microvascular 
hierarchy (point 1: 350 µm; point 2: 90 µm; point 3: 45 µm; point 4: 10 µm dia.). (b) 3D 
confocal microscope scan of a branched microvascular network embedded in acrylic 
loaded with Rhodamine B dye. These data reveal the general features of the network 
morphology and confirm the ability to pump liquids through the microchannels. Scale 
bar, 1 mm. (c) Branched microvascular network embedded in a 1.5x5x8 cm molded PLA 
block ((scale bar, 0.5 cm; point 1: 180 µm; point 2: 70 µm; point 3: 40 µm; point 4: 20 
µm dia.). 
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3.5 MicrovascularNetwork Morphology 
Microchannels produced by electrostatic discharge mimic many attributes of 
naturally occurring vasculature where a well-defined global architecture persists despite 
the fact that no two networks are completely identical at all structural levels. The extent 
of this self-similarity becomes evident when we compare the branching characteristics of 
microchannel networks produced in three identical acrylic blocks exposed todifferent 
irradiation and discharge conditions (Fig. 3.5).Discharge networks were first embedded 
in each block using the grounded contact method (Fig. 3.1a). The blocks were then 
exposed to additional cycles of re-irradiation and spontaneous discharge, during which 
the embedded branched network continued to grow and expand159.Quantitative 
descriptors of the corresponding network morphologies based on consideration of a 
bifurcation model where a parent channel of diameter d0 splits intotwo daughter 
channels of diameters d1 and d2(Fig. 3.5a)were then extracted from analysis of images 
acquiredalong the midplane of each block. Multiple branchesoriginating from exactly the 
same point (trifurcations, etc.) were rarely observed. Remarkably, these data indicate 
that although the network density increases with each subsequent irradiation/discharge 
cycle, the average bifurcation angle and fractal dimension remain relatively unchanged 
and within physiological ranges observed in living systems (Table 3.1)162-164. These 
results demonstrate that all three networks share a fundamentally similar underlying 
architecture despite clear differences in network density. A more detailed picture was 
obtained by examining the variation in the ratio between the parent and daughter cross-
sectional areas (area ratio) and the bifurcation index (Fig. 3.5b–d). These data show that 
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the network comprises a distribution of bifurcations ranging from symmetric (d2/d1 = 1) 
to asymmetric (d2/d1<1) that are not only self-similar among all three blocks, but also 
mirror the features of physiologically relevant vasculature165. 
The architecture of naturally occurring vascular networks isoften described in 
terms of Murray’s law61, a model based onenergy minimization arguments that predicts a 
system-wide state of uniform shear stress corresponds to a global scaling of flow rate 
with the cube of vessel diameter20, 21, 55. Considering the case of bifurcations from a 
parent channel to two daughter channels, Murray’s law implies that d0k= d1k+ d2k where 
a value of k = 3 is predicted under ideal conditions (e.g., laminar, non-pulsatileflow). 
Analysis of the branched networks in Fig.3.5 yield exponents in the vicinity of 
2.1<k<2.3 (Table 3.1), within the range of available physiological data (deviations from 
k = 3 are common and attributable to departures from the idealized flow conditions 
assumed in the formulation of Murray’s law)29, 30, 164, 166, 167.Furthermore, it is notable 
that the physics of electrostatic discharge phenomena yield networks whose scaling 
exponents naturally approach k = 2 owing to the requirement for the minimization of 
electrical resistance168. Optimal networks for diffusive mass transport inherently share 
this k = 3 scaling(consistent with physiological observations indicating a transition from 
k = 2 in larger vessels near the base of arterial trees to k = 3in the capillary beds28), an 
observation further supported byfractal dimension values in the vicinity of 1.8169. These 
data imply that branched microchannels constructed using electrostatic discharge 
inherently possess morphologies ideally suited to satisfy the transport requirements of 
tissue engineering applications. 
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Figure 3.5.Microvascular networks produced under different irradiation/discharge 
conditions incorporate morphologically similar branching characteristics. (a) 
Quantitative branching parameters corresponding to bifurcation from a parent channel of 
diameter d0 into two daughter channels of diameters d1 and d2.(b-d) Characterization of 
microchannel networks originating in the center of three identical 1x3x3 inch polished 
acrylic blocks subjected to (b) 1, (c) 2, and (d) 3 successive irradiation/discharge cycles. 
All three networks exhibit a similar relationship between the area ratio and bifurcation 
index. despite differences in the overall network density (inset). The area ratio data are 
mostly clustered about the limiting theoretical range between 1 and 21/3 corresponding to 
Murray’s law exponents of k = 3 and 2 respectively151. 
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Table 3.1.Quantitative characteristics of branched microchannel networks. 
 
Irradiation/ 
discharge 
cycles 
Network 
density (%) 
Average 
bifurcation 
angle θ (°) 
Fractal 
dimension 
Murray’s law 
exponent, k 
1 17.3 52.8 1.79 2.14 
2 24.8 44.0 1.88 2.16 
3 29.0 45.6 1.88 2.32 
 
Parameters were determined from analysis of images reconstructed from microvascular 
networks embedded in acrylic blocks upon exposure to multiple irradiation/discharge 
cycles (Fig. 3.5b-d). Network density represents the fraction of the total image area 
occupied by the microchannel network (i.e., number of pixels associated with the 
network divided by total pixels in the image). 
 
3.6 Summary 
We introduce a nearly instantaneous method to embed branched 3D 
microvascular networks inside plastic materials. In this microfabrication process, a high 
level of electric charge is first implanted inside a polymer dielectric using electron beam 
irradiation. The accumulated energy is then discharged in a controlled manner to locally 
vaporize and fracture the material, leaving behind a network of branched microchannels 
arranged in a tree-like architecture with diameters ranging from approximately 10 µm to 
1 mm. Modulating the irradiation profile and discharge locations allows the networks’ 
morphology and interconnectivity to be precisely tailored. Interconnected networks with 
multiple fluidic access points can be straightforwardly constructed, and quantification of 
their branching characteristics reveals remarkable similarity to naturally occurring 
vasculature. This method can be applied in a variety of polymers, and may help enable 
production of organ-sized tissue scaffolds containing embedded vasculature. 
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CHAPTER IV 
FABRICATION ENDOTHELIALIZED OF CIRCULAR  
MICROCHANNEL NETWORKS 
 
4.1 Introduction 
Physiological systems rely on branched flow networks to achieve efficient 
transport within extended 3D spaces170, making the ability to replicate these features in 
vitro critically important in many fields1, 2, 35, 171-173. Planar micromachining is the most 
mature technology to construct synthetic microvascular networks, but it is not an ideal 
solution because cross-sectional profiles of the corresponding microchannels are 
typically square, rectangular, or trapezoidal. These topographies make it challenging to 
establish fully endothelialized microenvironments due to nonuniform cell seeding in the 
sharp corner regions92. Wall shear stresses can also vary widely at these locations93, 94, 
potentially impacting flow-based studies95-99. Rounded cross-sectional profiles are 
therefore highly desirable, and recent progress toward this goal has made it possible to 
construct semi-circular topologies by applying methods such as photoresist-based 
molding39, wet etching42, electroplated molding52, laser ablation56, and micromilling101. 
Circular cross-sections are then produced by aligning and bonding two substrates 
imprinted with complementary semi-circular patterns. Sacrificial approaches also permit 
circular profiles to be obtained upon embedding and removal of soldering wire174, sugar 
fibers78, and polylactide fibers175. Post-fabrication circularization has also been 
demonstrated by coating rectangular microchannels with solvent diluted poly(dimethyl 
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siloxane) (PDMS)176-178 and poly(methyl methacrylate) (PMMA)179. Alternatively, 
direct-ink writing has been employed to construct networks with circular cross-sectional 
shapes in hydrogel matrices albeit in a low throughput serial format65. In addition to 
limitations in fabrication technology, material specific issues also pose challenges to 
long term culture and biological response studies, particularly in the case of PDMS 
which is susceptible to nonspecific surface absorption and leaching of uncured 
monomer180, 181. 
 
4.2 Pressurized Air Deformation Process 
We have developed a new strategy to overcome many barriers that have limited 
previous efforts to construct synthetic microvascular networks. Our approach is based on 
pressure-assisted expansion of biocompatible poly(lactic acid) (PLA) substrates—a 
versatile process that can be readily applied in both 2D and 3D branched networks 
incorporating a heirarchy of microchannel diameters. This treatment simultaneously 
renders the interior surfaces circular and smooth, yielding a robust cell-favored 
microenvironment capable of supporting uniform seeding and culture of endothelial 
monolayers under continuous flow. Rigid microchannels are first constructed in PLA by 
molding from a negative PDMS template (Fig. 4.1a). The resulting microchannels with 
rectangular cross-section are subsequently enlarged and shaped into circular profiles by 
heating the substrate and injecting compressed air under constant pressure (Fig. 4.1b-d). 
When pressurized air is injected in the glassy state, the interior air pressure force (Fair) is 
counteracted by resistance from the surrounding rigid wall (Fw) (Fig. 4.1b and e). 
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Increasing the temperature above the glass transition (Tg ~ 55 – 58 °C) causes the 
material to enter a rubbery regime where the interior air pressure force overcomes the 
wall resistance (Fig. 4.1c and f). Incubation at 80 °C for 8 min is sufficient to allow the 
interior of a 4 mm thick substrate to reach equilibrium (confirmed by placing a 
thermocouple probe between PLA layers; thermal conductivity = 0.13 W/m·K, specific 
heat capacity = 2,135 J/kg·K). Under these conditions, the microchannel initially 
assumes an elliptical profile, ultimately attaining an enlarged circular cross section after 
~ 20 min (Fig. 4.1d and 4.1g). The process is arrested by quenching the sample at room 
temperature. 
 
4.3 Mechanism of Polymer Deformation 
The final microchannel diameter is governed by temperature, applied pressure, 
and incubation time. This interplay can be captured by a dynamic equilibrium associated 
with the internal stress balance )(
)(
th
tPR
=τ where τ is the hoop stress, P is the air pressure, 
R(t) is the channel radius, and h(t) is the wall thickness. When the wall thickness is much 
greater than the channel radius (h0>>R0; h0 and R0 are initial values), the time variation 
of the wall thickness during enlargement can be approximated as h(t) = h0 – (R(t) – R0). 
The deformation can be expressed in terms of the rate of strain , yielding 
the following upon substitution into stress balance , where µ is 
the material’s viscosity coefficient. 
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Figure 4.1.Enlargement of PLA microchannel diameters by pressure-assisted 
expansion. (a)Microchannel with initially rectangular cross-section in PLA. (b-c) 
Pressurized air is injected upon heating the PLA to the rubbery state (above glass 
transition temperature and below melting temperature) causing the interior air pressure 
force to exceed the wall resistance.The channel eventually assumes a circular shape. (d-
g) Cross-sectional images of PLA microchannels(d) untreated; (e) 80 °C, 15 psi for 10 
min;  (f) 80 °C, 15 psi for 15 min; and (g) 80 °C, 15 psi for 25 min (expansion ratio = 5; 
bars, 50 µm). 
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This time dependent equation then can be solved to describe the relationship 
between inflation time and channel enlargement. Although this relatively simple model 
is strictly valid for thin walled tubes, good agreement is observed between these 
predictions and our experimental data displaying an exponential increase in channel size 
with time (Fig. 4.2a). Circular cross sections can be obtained from initially rectangular 
microchannels within 20 min over a wide range of aspect ratios (initial height/width = 
0.07 – 2.23) (Fig. 4.2b), with expansion ratios ranging from 5 – 10 (Fig. 4.2c). Elliptical 
cross sections are produced at shorter inflation times, while bursting eventually occurs in 
the long time limit. 
 
4.4 Multi-Layers and Branched Microvascular Networks 
We applied the air inflation technique in simplified 3D constructs using a seven 
layer thick synthetic microvascular network in PLA (Fig. 4.3a). The initially rectangular 
cross section of all four generations in the branched architecture became circularized in a 
single inflation step, with all microchannels attaining an aspect ratio close to unity. Our 
method therefore is not only capable of circularizing the cross sectional profiles, it also 
enables the process to be simultaneously performed across a broad range of 
microchannel diameters (~ 1.5 mm to 50 µm). 
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Figure 4.2.Characterization and optimization of inflation process. (a) Experimental 
results (dots) and analytic model (dash lines) show expansion of rectangular 
microchannels as a function of time and channel width (w’). Three different processing 
conditions were considered: 80 °C at 15 psi (red), 80 °C at 10 psi (green), and 70 °C at 
10 psi (blue). (b) Effect of initial rectangular channel aspect ratio (80 °C at 15 psi). (c) 
Cross sectional images of channels with different aspect ratio before and after inflation 
under the same conditions as (b) (white bar, 100 µm; black bar, 1000 µm). Experiment 
data: mean ± SD (n = 3). 
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This is a significant finding because although similar network structures 
incorporating rectangular cross sections can be constructed using conventional 
lithography and molding approaches48, 171, 173, 182, the microchannels in every branching 
generation inherently retain the same channel height. This creates a problematic situation  
because internal shear rates are therefore highly nonuniform (e.g., low aspect ratio 
channels display much higher shear rates in the vertical direction than in the horizontal 
plane), generating severe internal shear stresses that are physiologically unfavorable. We 
also applied the inflation method in a fully 3D synthetic microvascular network 
embedded in PLA using electrostatic discharge81. The interior microchannels were 
subsequently deformed, yielding a global increase in channel diameter throughout the 
network as well as smoother sidewall profiles (Fig. 4.3b). Unlike liquid etchants, 
pressurized air penetrates the entire network, yielding identical topographies in each 
branch. 
 
4.5 Endothelialized Circular Microchannel Network 
To study cell morphology under dynamic flow conditions during long term 
culture, and to demonstrate feasibility of employing PLA substrates for cell-based 
studies, bovine aortic endothelial cells (BAECs) were harvested from a static petri dish 
environment and seeded within a branched circularized synthetic microvascular network. 
We continually perfused culture medium at constant flow rate in a closed recirculation 
loop so that cell signaling interactions could be maintained.  
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Figure 4.3.The application of air deformation process.(a) Seven layers stacked PLA 
branched networks before and after treatment. Bar, 300 µm. (b) 3D branched 
microchannel network embedded in 1.5 cm x 5 cm x 8 cm molded PLA block by 
electrostatic discharge. Before treatment, the microchannel diameters are not optimal for 
cell seeding. After air inflation, the average channel diameters are significantly widened 
throughout and the sidewall topology becomes smoother. Bar, 500 µm. All channels 
mentioned above were injected with 15 psi of pressurized air for 20 min at 80 °C. 
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Live cell confocal microscopy revealed uniform attachment and growth of a 
confluent BAEC monolayer along the microchannel walls (Fig. 4.4a).Endothelial cells 
could be successfully seeded within four generations of a branched microchannel 
network whose smallest channel size was below 50 µm (Fig. 4.4b), with viability 
maintained for up to 2 days. However viability and morphology could be maintained for 
at least 5 days in straight microchannels under identical continuous flow conditions 
(Fig.4.4c, due to the long term incubation, CellTracker stained cells displayed weak 
florescence after day 5). These differences reflect unique challenges associated with 
culture in synthetic microvascular networks as compared with previous studies focused 
on straight microchannels. First, the hierarchy of channel sizes leads to differences in 
local cell density within each branch. Consequently, the same seeding conditions may 
place gaps between adjacent cells in larger channels while simultaneously imposing 
crowding and overlap in smaller peripheral branches. The less severe sidewall curvature 
in larger microchannels (> 100 µm diameter) is also more favorable to establish uniform 
coverage, whereas very different environments emerge in smaller capillaries whose 
dimensions approach those of the flattened cells (~ 50 – 100 µm in length, 10 – 20 µm in 
width). The ability to successfully seed BAECs throughout a branched network (Fig. 
4.4d) is therefore a significant finding because it represents a more physiologically 
realistic scenario than has been previously considered. More work is needed, however, to 
identify flow conditions that optimally achieve uniform long-term culture throughout the 
entire network. 
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Figure 4.4.  Imaging of bovine aortic endothelial cells (BAECs) cultured in circular 
microchannels.(a) Illustration of image acquisition in top, middle and bottom focal 
planes. Confocal images show 100 µm of microchannel walls were seeded with 
endothelial cells and confirmed that cells can be confluently cultured in monolayer 
surrounded the channel wall after 3 days.  CellTracker was used in this study to 
continuously observe live cells. (b) BAECs can also be cultured within circular branched 
network with diameter range lower than 50 µm. The cells are observed in bright view 
and (c) Fluorescent images show BAECs survived and maintained cell morphology after 
5 days. (d)BAECs were seeded in four generations of branched network and covered all 
channel walls. Bar, 50 µm. 
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4.6 Summary 
Synthetic microvascular networks are essential to enable in vitro studies of cell 
biology, biophysics, hemodynamics, and drug discovery, as well as in applications 
involving tissue engineering and artificial vasculature. But current limitations make it 
challenging to construct networks incorporating a hierarchy of microchannel diameters 
possessing cell-favoring circular cross-sectional topographies. We report a new approach 
that overcomes these limitations by employing pressure-assisted expansion of 
biocompatible poly(lactic acid) (PLA) substrates. These controllable processes can 
precisely contribute interconnected microchannel networks with wide range of diameter 
for each level of branching and circular cross-sections geometry within 3D or pseudo-3D 
substrate. Additionally, in vitro cell culturing demonstrated confluent cell monolayer 
endothelialized in microvasculature chip and indicated that this platform can potentially 
provide a bio-mimicking environment for advanced biological and clinical studies. 
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CHAPTER V 
ENZYMATIC SCULPTING OF NANOSCALE AND MICROSCALE  
SURFACE TOPOGRAPHIES* 
 
5.1 Introduction 
Living systems display complex structured nano- and micro-scale topologies that 
orchestrate a host of physical and biological functions183-187. But these features can be 
challenging to replicate using conventional planar methods188, and nanometer-scale 
structures cannot be readily constructed without dedicated facilities189-193. Herein we 
show how enzymatic activity can be harnessed to fashion complex nano- and microscale 
surface topographies on biodegradable substrates. Coordinated patterning and machining 
are accomplished by manipulating interactions between an enzyme, substrate, and 
protein inhibitor. In this way, we are able to construct nanochannels, microchannels 
containing embedded features templated by the substrates crystalline morphology, and a 
membraneless filter capable of isolating rare cells from whole blood with a throughput 
that is orders of magnitude greater than currently possible. 
 
 
 
 
____________ 
*
 Part of the data reported in this chapter is reprinted with permission from: Enzymatic 
sculpting of nanoscale and microscale surface topographies by Huang, J.H., Jayaraman, 
A. and Ugaz, V.M. Angew Chem Int Ed Engl51, 9619-9623 (2012).©2012 by WILEY-
VCH Verlag GmbH & Co. KGaA, Weinheim.  
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In addition to enabling molecularly imprinted surface landscapes mimicking 
those in living systems to be fashioned by a straightforward process accessible in 
virtually any laboratory, considerable potential exists to exquisitely control the 
underlying biochemicalinteractions by employing enzymes and substrates with 
appropriately engineered properties. 
 
5.2 EnzymaticBiosculpting 
Our bioinspired machining approach exploits the enzymatic activity ofproteinase 
K (PK), a serine protease capable of cleaving peptide bonds with particular affinity 
toward alanine-alanine linkages194. Poly(lactic acid) (PLA) serves as a convenient 
substrate because it is also susceptible to this degradation mechanism owing to structural 
similarities between lactic acid and alanine. Machining is initiated when PK is 
transported from the bulk environment to the PLA surface, after which enzyme-substrate 
complexation catalyzes surface reactions yielding low molecular weight cleavage 
products that subsequently become hydrolyzed and are released into the bulk along with 
dissociated PK (Fig. 5.1a). Patterned machining is accomplished by directing an 
aqueous PK solution through a microfluidic template (constructed from poly(dimethyl 
siloxane) (PDMS) using conventional soft lithography (see also Chapter II) so that the 
ensuing enzymatic degradation imprints a replica of the flow path into a PLA substrate 
on the microchannel floor (Fig. 5.1b). Characteristic degradation rates of 2 µm/h are 
achievable in a 300 µm-wide, 10.7 mm-long microchannel (Fig. 5.1c). Feature depths 
increase monotonically with enzyme concentration up to about 4 µM, above which 
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surface complexation sites become saturated (Fig. 5.1d)195, 196. Machining also reflects 
temperature-dependent enzymatic activity, which occurs about 7 times faster at 37 °C 
than at room temperature (Fig. 5.1e). These rates enable nanometer-size features to be 
easily imprinted, as illustrated by construction of a 170 nm deep channel via injection of 
a PK solution at 2 µL/min for 3 h at room temperature (Fig. 5.1f). 
 
5.3 Competitive Interaction between Enzyme and Inhibitor 
Complex cross-sectional topologies can be fashioned by establishing gradients in 
enzyme concentration that spatially regulate the machining process. The macromolecular 
architecture of PK confines lateral diffusion (D = 8.1 x 10–7 cm2/s at 25 °C152), enabling 
the dimensions of imprinted features to be maintained over a much greater downstream 
distance than possible using conventional small-molecule chemical etchants (e.g., D = 
1.6 x 10–5 cm2/s for hydrofluoric acid (HF) etching of glass at 25 °C197). Feature 
definition is further enhanced by replacing the buffer stream with a 1% w/v aqueous 
solution of bovine serum albumin (BSA) to establish a competitive interaction that 
inactivates the laterally diffusing enzyme before it can attack the PLA (Fig. 5.2a). The 
resulting complexation between PK and BSA enables sharper boundaries to be 
established between the machined and masked regions. 
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Figure 5.1.Enzymatic nano- and micro-machining. (a) Biochemical degradation cycle 
between proteinase K (PK) and the PLA substrate. (b) Cross-sectional schematic (above) 
illustrating how machining is performed by directing an aqueous PK solution through a 
PDMS microchannel template bonded to a PLA sheet (bar in SEM image below, 200 
µm). (c) Feature depth versus time ([PK] = 6.92 µM (0.2 mg/mL), 5 µL/min, 37°C). (d) 
Depth versus enzyme concentration (5 µL/min, 37°C, 16 h). (e) Depth versus 
temperature ([PK] = 6.92 µM, 5 µL/min, 16 h). (f) A nanochannel (170 nm deep) is 
constructed by injecting PK into a PDMS  template (left) for 3 h at 25 °C. Machining is 
laterally confined within a ~ 4 µm-wide zone by hydrodynamic focusing of PK between 
co-injected streams of bovine serum albumin (2 µL/min each stream; see Fig. 6.2 and 
Methods). The z-axis of the AFM surface profile (right) is expanded to show detail. 
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Patterning is controlled by adjusting the relative concentrations and flow rates of 
enzyme and BSA in order to manipulate the balance between convection and diffusion 
(expressed in terms of a Péclet number Pe = uL/D; where u, l, and D represent the 
characteristic flow velocity, diffusion length, and diffusion coefficient, respectively). In 
conventional laminar flow patterning, convection-dominated confinement of chemical 
etchants is only possible at high flow rates (Pe ~ 5 x 103 for HF etching of glass at u = 
0.1 m/s)198-200. In contrast, enzymatic machining employs macromolecular species that 
display greatly reduced diffusivities, enabling high Pe to be maintained at low flow rates 
(Pe ~ 4 x 103, u = 0.005 m/s) to minimize reagent consumption and operate below the 
threshold for undesirable inertial effects (i.e., Dean vortices that would disrupt pattern 
fidelity along curved flow paths). We applied a convection-diffusion model to capture 
this interplay, yielding close quantitative agreement between the cross-sectional profile 
of the machined microchannels and the predicted distribution of free (uncomplexed) PK 
(Fig. 5.2b and Fig. 5.3). 
 
5.4 Kinetic Model 
Direct observation using fluorescently labeled BSA reveals the lateral 
concentration profile, with a 10 % w/v solution experiencing significant transport into 
the adjacent stream (Fig. 5.3). This effect acts to confine the etching zone by promoting 
strong complexation with PK.  
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Figure 5.2. Machining is governed by a competitive interaction between enzyme, 
substrate, and inhibitor. (a) When PK (red) and BSA (green) are co-injected into a 
microchannel, a localized interfacial zone of PK-BSA complexation establishes the 
boundary of the machined region. (b)Profilometery measurements of machined profiles 
obtained 1 cm downstream from the inlet (black line; left ordinate) as a function of BSA 
concentration are overlaid with predicted lateral concentration profiles of free PK and 
PK-BSA complex (red and blue lines, respectively; inner right ordinate) and BSA 
normalized to the injected concentration (green line; outer right ordinate). Machining 
conditions: [PK] = 6.92 µM in the bulk solution, 5 µL/min, 37°C, 16 h, [BSA]0 = 0.15 
and 1.5 mM for 1 and 10 % solutions, respectively. 
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Figure 5.3.Concentration distribution of enzyme and inhibitor.(a) When PK 
(etchant, red) and BSA (inhibitor, green) are co-injected into a microchannel, a localized 
interfacial zone of PK-BSA complexation establishes the boundary of the etched region. 
(b) The lateral concentration profile of FITC-BSA is visualized using fluorescence 
microscopy at three different concentrations (images were acquired in a 500 x 500 µm 
window located 1 cm downstream from the inlet, dashed line indicates centerline). (c) 
Predicted BSA concentration profile obtained by numerical simulation of the 2D 
convection-diffusion model in Equations 5.1 – 5.3 (dashed line indicates centerline). (d) 
Predicted concentration profile of free (uncomplexed) PK defining the effective etching 
zone (dashed line indicates etched boundary where the enzyme concentration approaches 
zero; effective width of the etched zone is indicated). 
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The underlying mechanics governing this interplay can be captured in terms of a 
convection-diffusion framework, yielding a system of differential equations expressing 
the concentrations of PK, BSA and PK-BSA complexes (CPK, CBSA, and CPK-BSA, 
respectively). 
dCPK
dt
+ ∇⋅ −DPK∇CPK + CPKu( ) = koff CPK −BSA − konCPKCBSA    (5.1) 
dCBSA
dt
+ ∇⋅ −DBSA∇CBSA + CBSAu( ) = koff CPK−BSA − konCPKCBSA    (5.2) 
dCPK−BSA
dt
+ ∇⋅ −DPK−BSA∇CPK−BSA + CPK −BSAu( ) = konCPKCBSA − koff CPK −BSA   (5.3) 
 
Here DPK, DBSA, and DPK-BSA are the diffusivities of each species in solution, and 
the bulk fluid flow is directed axially along the length of the microchannel (the x-
direction) with characteristic velocity u. The association and disassociation rate 
constants (kon and koff, respectively) represent PK complexation with BSA (i.e.,
BSAPKBSAPK
on
off
k
k
−↔+ ). 
The transport model in Equations 5.1–5.3 was numerically evaluated using 
COMSOL Multiphysics (version 4.0a, COMSOL, Inc.). The two-dimensional 
convection-diffusion mode was selected from COMOSL’s model library, and the 
computational domain was discretized into a mesh of quadrilateral elements. Properties 
of water at 37 °C (ρ = 993.36 kg/m3, µ  = 6.9 x 10–4Pa·s) were used to represent all 
solutions (PK, buffer, BSA). Diffusion coefficients for PK, BSA, and PK-BSA complex 
were estimated to be 1.22 x 10–6, 9.25 x 10–7, and 8.2 x 10–7 cm2/s, respectively based on 
their molecular weight (T = 37 °C)152. Association and disassociation rate constant 
values of kon = 4 M–1 s–1 and koff  = 10–4 s–1 were assumed based on literature data201. The 
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flow velocity u was determined by analysis of the fully developed two-dimensional 
velocity profile obtained by solving the steady-state Navier-Stokes equations in the 
etching template geometry (50 x 500 µm cross-section, 5 µL/min flow rate). Since 
transport of PK to the PLA surface is governed by the near-wall flow field, a velocity of 
u = 4.67 x 10-4 m/s was chosen as a representative value that best fit the experimentally 
observed BSA concentration profile (corresponding to a distance of 1.1 µm from the 
PLA surface; Fig. 5.4). 
 
5.5 Microchannels with Irregular Cross Section 
More intricate topologies where the feature depth varies along the 
microchannel’s cross-section can be fashioned by sequentially changing the composition 
and flow conditions (Fig. 5.5a). We demonstrated this by employing a microchannel 
template with three independent inlets to fashion a cross-sectional profile incorporating a 
weir-like centerline barrier oriented parallel to the flow direction. First, BSA solution 
was injected into the center steam while PK was introduced into both outer streams for 
4.7 h at 37 °C (2.3 µm/h degradation rate), machining the PLA substrate to a depth of 10 
µm on either side of the central zone. 
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Figure 5.4.Simulated velocity profile.The velocity profile within a microfluidic etching 
template (50 x 500 µm cross-section, 5 µL/min flow rate) simulated by solving the 
steady-state Navier-Stokes equations. The velocity at a distance of 1.1 µm from the PLA 
surface (4.67 x 10–4 m/s) was selected for subsequent calculations to evaluate the 
transport model in Equations 5.1 – 5.3. 
 
 
 
Next, BSA was infused into both the center stream and one of the outer streams 
for 8 h, yielding different depths on each side of the microchannel. Finally, PK was 
injected into all three inlets for 3 h to define the height of the central barrier. When 
completed, this process produced a cross-sectional profile incorporating three different 
 80 
 
depths (13, 6, and 20 µm from left to right; Fig. 5.5b)—a topology preserved along the 
entire length of the microchannel (Fig. 5.6a). Feature sizes can be further tuned by 
varying the relative flow rates of BSA and PK to hydrodynamically focus the desired 
streams (Fig. 5.6b). Topologies incorporating continuously varying cross-section 
dimensions, challenging to build using conventional planar methods, can be readily 
constructed by imposing suitable enzyme concentration gradients (Fig. 5.6c). The 
machined structures can be used as-is, or alternatively the rigid PLA substrate can serve 
as a re-usable master mold for replication in PDMS by soft lithography (see also Fig. 
2.3). Thus, even though micron-scale enzymatic machining may be relatively slow, the 
resulting structures are amenable for mass-production. 
 
5.6 Microchannel with Crystallized Structures 
The highly specific nature of enzyme-substrate interactions can also be exploited 
to enable direct imprinting of molecular-scale topologies. We explored this potential by 
taking advantage of the machining rate selectivity to PLA crystallinity (increasing the 
degree of crystallinity from 0 to 50 % yields a ten-fold decrease in the material 
degradation rate202) to embed morphological features associated with the substrate’s 
crystalline domains within a fluidic channel (Fig. 5.7a). The crystalline morphology is in 
turn governed by thermal history (annealing time and temperature, cooling rate) and 
material properties (molecular weight, stereoisomers and their blends), permitting broad 
control over the imprinted topologies (Fig. 5.8). Machining after the PLA is 
continuously cooled from the melt exposes a dendritic surface topology (Fig. 5.7b), 
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whereas an array of obstacles reflecting the size and density of spherulitic crystalline 
domains emerges when PK is injected following a low-temperature anneal (70 °C for 8 
h203) (Fig. 5.7c). In this way, the extent and distribution of crystallinity within the 
substrate can be manipulated to enable post-like arrays with tunable size and density to 
be embedded within a fluidic channel in a lithography-free manner.  
 
 
 
 
 
Figure 5.5 Strategy of enzymatic etching.(a) Alternating flows of PK and BSA are 
introduced to fashion a microchannel whose depth varies along the cross-section. 
Surface profiles are obtained 0.5 cm from the inlet ([PK] = 6.92 µM, [BSA] = 1% w/v 
(150.6 µM), all flow rates = 5 µL/min). (b) SEM image of microchannel incorporating 
an inner flow channel, central barrier, and outer flow channel with depths of 13, 6, and 
20 µm, respectively (from left to right). After machining, the PLA microchannel is 
thermally bonded to a flat PLA sheet to form an enclosed flow network (bar, 50 µm). 
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Figure 5.6.Diverse etched structures.(a)Profilometry measurements as a function of 
downstream position confirm that the etching profile is maintained along the entire 
microchannel length (etching conditions same as in Fig. 5.5a; bar, 1 mm) (b) Different 
flow rates can be applied in each stream to further control the size of the etched zone by 
hydrodynamic focusing (etching conditions same as in (a) except that flow rates of 10 
and 0.5 µL/min were applied in the PK and BSA streams, respectively; bar, 300 µm). (c) 
PK and buffer are co-injected into a microfluidic gradient generating template and 
allowed to etch PLA at 37 °C for 16 h (22 µL/min, Re = 0.16, Pe = 0.09; bar in photo, 1 
mm). The etched profile shows a continuously varying depth corresponding to the lateral 
concentration profile of PK (bar in SEM image, 300 µm). 
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Figure 5.7.Machining molecularly templated surface topographies. (a) 
Morphologically governed selectivity is made possible by differences in the rate of PK-
mediated degradation between hydrolysis-resistant crystalline domains and amorphous 
regions containing condensed hydrophilic and catalytic terminal groups (–OH and –
COOH). (b) Machining after continuous slow cooling from 180 °C exposes dendritic 
features. (c) Machining after annealing at 70 °C for 8 h embeds an array of post-like 
obstacles within the microchannel (a 3D topology is evident in the SEM image, right). 
PK was injected at 37 °C for 2 h using the microchannel template in Fig. 3a (bars, 100 
µm). 
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Figure 5.8.Polymer crystal morphology.Morphological dependence on thermal history 
in crystallized PLA before (upper images) and after (lower images) enzymatic etching 
with 0.2 mg/mL PK for 2 h at 37 °C. The PLA samples were cooled from the melt (180 
°C) to room temperature (25 °C) as follows: (a) removed from 180 °C oven to room 
temperature; (b) annealed in oven at 80 °C for 1 h, then removed to room temperature, 
(c) annealed at 120 °C for 1 h, then removed to room temperature; and (d) cooled slowly 
(~ 10 h) to 25 °C in oven. Bar, 50 µm. 
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5.7 Summary 
We report how enzymatic activity can be harnessed as a tool to fashion complex 
nano- and micro-scale surface topographies on biodegradable substrates. Coordinated 
patterning and machining are accomplished by manipulating interactions between an 
enzyme, substrate, and protein inhibitor. In this way, we are able to construct 
nanochannels, microchannels containing embedded features templated by the substrate’s 
crystalline morphology, and an irregular cross section of microchannel capable of 
performing mixing, separation and other biological applications greater than currently 
possible. In addition to enabling molecularly imprinted surface landscapes mimicking 
those in living systems to be fashioned via a straightforward process accessible in 
virtually any laboratory, considerable potential exists to exquisitely control the 
underlying biochemical interactions by employing enzymes and substrates with 
appropriately engineered properties. 
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CHAPTER VI 
MEMBRANELESS HIGH-THROUGHPUT CELL SEPARATION  
 
6.1 Introduction 
There is a critical need for advanced filtration methods adaptable for separation 
of cells and cell-sized components from blood, specifically offering the capability to 
rapidly process large volumes (>mL/min flow rates)111, 204. Microfluidic technologies 
provide a natural platform to address these challenges, but these methods generally 
require timescales of hours (sometimes tens of hours) to process standard 5 mL samples, 
making them impractical for routine use. Another key area where high-throughput blood 
separation is important is analysis of rare cell biomarkers relevant to cancer (e.g., 
circulating tumor cells (CTCs)). Microfluidic methods based on micromachined 
filtration structures that act either alone (to provide size-selective isolation)125, 127, or in 
tandem with functionalized antibodies (to provide affinity capture) show considerable 
promise119, 205, but also suffer from limitations inherent to the filtration-based design. 
Most notably, achievable flow rates are typically very small due to the large pressures 
that must be applied to inject a cell laden suspension through the tiny internal pore-like 
networks. Consequently, highly diluted cell suspensions must often be used (making it 
necessary to process even greater volumes due to the rare nature of CTCs), and large 
internal shear stresses make recovery of viable cells challenging unless extremely low 
flow rates are applied (further increasing the analysis time). 
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We have developed a new filtration approach that overcomes these limitations. 
Our previous design was based on a microfluidic architecture incorporating an 
embedded weir-like barrier oriented parallel to the flow direction and extending along 
the entire centerline length of a microchannel206(see Chapter V). This arrangement, 
combined with the transverse centrifugal flow generated within the microchannel’s 
curved path, creates a driving force that transports smaller-sized components across the 
barrier from the inner lane to the outer lane while larger-sized species are retained in the 
inner lane207. In this chapter, we initially focused on inertial effects in the curved 
microchannel with central barrier and verify how efficiently smaller sized components 
can cross the barrier and be collected in the outlet. We unexpectedly find that unequal 
depths of two parallel flows also contributes a significantlyto separation performance. 
When the interplay between these effects is considered, we found that performance can 
be enhanced beyond what is possible if either mechanism is applied alone. Separation 
efficiency was quantified and the flow mechanism was verified by tracking motion of 
fluorescent particles in three scenarios: (1) curved channel with equal depth, (2) straight 
channel with unequal depth, and (3) curved channel with unequal depth. High-
throughput harvesting of blood components and cancer cells through separation devices 
demonstrates the feasibility of biological and clinical applications. 
 
6.2 Limitation 
Passive separation in mirofluidic systems without external equipment which 
purely relies on flow phenomena and channel geometry has been widely studied and 
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applied to separate blood components208-212, microorganisms213, 214 and even rare cells125, 
128, 215-217
. However, a critical problem emerges when using microfluidic device as filter 
to separate particles or cells from mixture because the most common fabrication method 
is soft lithography utilizing PDMS (polydimethylsiloxane). The soft mechanical property 
of the PDMS elastomer often limits filtration performance due to deformation of the 
channel structures. The difficulty to fabricate complex microstructure geometries 
constrains further development of these systems.  
To overcome these limitations described above, we have developed a novel 
fabrication method employing enzymatic etching on the rigid biodegradable material 
polylactic acid (see Chapter V). Instead of forcing a particle- or cell-laden suspension to 
flow through tiny pores in a membrane filter, this design employs a weir-like centerline 
barrier embedded within a microchannel. In this way, the resulting secondary forces 
either by centrifugal or pressure difference act to transport the suspended components 
across the centerline barrier from the inside wall to the outside wall, with only those 
smaller than the barrier gap able to pass across. In this chapter, we study the separation 
efficiency of microsphere particles by performing the continuous filtration in straight 
and curved microchannels with an equal or unequal depth on each side of weir structure. 
 
6.3 Even Height Curved Channel 
Flow in curved channels has been studied and described in terms of a lift force 
from the wall, a centrifugal force, a Saffman and Magnus forcers, and Dean vortex 
flow218.Lateral particle migration in curved microchannel due to centrifugal effect on the 
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fluid has recently been studied and applied in separation of different sized particles219, 
220
. This secondary flow, also called Dean flow, is introduced by symmetrically counter 
rotating vortices in the top and bottom halves of the microchannel and can be 
characterized in terms of dimensionless “Dean number” κ207, the secondary flow is 
quantified by the relative magnitudes of inertial and centrifugal forces to viscous forces. 
This Dean number can be described as κ = (Dh/2R)0.5Re, where Dh is the channel 
hydraulic diameter,  R is the flow path radius of curvature, and Re refers to Reynolds 
number (Re). 
 To study the effect of secondary flow caused by Dean vortices, we used 
enzymatic micromachining to construct a curved microchannel with inner and outer 
lanes interconnected by a micro-scale gap that can only allow particles smaller than a 
certain size to cross the barrier while larger sized particles remain in the original stream. 
Here, we used 2 µm diameter fluorescent particles to monitor flow paths in the inner and 
outer lanes at different flow rates (0.1, 0.5, 1.0, 1.5, 2.0, and 2.5 mL/min). At low flow 
rates (0.1 mL/min), centrifugal effects are not strong enough to drive lateral particle 
transport, and the laminar flow profile is maintained along the channel. As the flow rate 
increases, two counter-rotating vortex profiles are generated separately in both inner and 
outer lanes in the curved region (Fig. 6.1a). Particles then begin to follow the rotating 
vortices. When the particles in the upper vortex move close to the central gap, the 
particles are ableto cross the barrier and enter the outer lane.   
In Fig. 6.1b, the injection of two different dye-labeled streams verified that when 
at higher flow rate (also high κ), the inner stream near the barrier wall migrates toward 
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the inner wall while the stream near the inner wall is transported across the central 
barrier and toward the outer wall. These flowpatterns explain how particles trapped in 
rotating vortex, this Dean vortex can act the same behavior like dyed streams are 
transported to the inner wall and subsequently cross the barrier into the outer lane (Fig. 
6.1c). The barrier structure,therefore, acts as a transverse filter to exclude large particles 
from entering the outer lane. In straight region before the curved region in barrier embed 
microchannel, fluid even at high flow rate is still in laminar flow regime characterized 
by Reynolds number (Re = VD/ν<< 100, where V is the flow velocity, Dh is the 
hydraulic diameter of channel, and ν is the fluid kinematic viscosity). Particles, thus, 
remain in the inner lane until entering curved region. In Fig. 6.1d, the fluorescent 
particle streamline image shows the agreement of particle migration with the flow 
pattern observed from dye-labeled streams. 
 
6.4 Uneven Height Straight Channel 
In addition to the transverse secondary flow, the viscosity difference between the 
two injected streams has been studied and applied to analyze diffusion coefficient of 
small molecules or biological samples221. However, parallel flows with a pressure 
difference between them have not been as widely studied. Since the enzymatic sculpting 
technique is capable of performing micromachining in cross-section to overcome the 
current fabrication limitation of complex topologies, we constructed a straight 
microchannel with two uneven height lanes divided with a central barrier. 
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Figure 6.1.Lateral migration of particles in even height of curved channel with 
central barrier. (a) Schematic of barrier embedded microchannel cross section. Dean 
vortex occurs in curved channel at high flow rate and force small particles travel across 
the barrier into outer region. (b) Top-view image of two streams labeled with blue and 
yellow dye in a curved microchannel at flow rate of 2 mL/min (inner and outer lanes: 40 
µm deep, centerline barrier gap: 5 µm deep, radius of curvature: 500 µm). (c) Schematic 
of the top view of a microchannel and particle movement in curved channel. (d) 
Fluorescence image illustrates 2 µm of particles migrate from inner lane across the 
barrier to outer lane at flow rate of 2 mL/min.  
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An initial pressure difference exists between shallow and deep lanes in the entry 
region can be described by L
wh
QL
wh
QPPP
ds
ds ∆−∆=∆−∆=∆ 33
1212 µµ
,
 where µ represents 
viscosity of fluid, Q is flow rate, w are the width of lane, hs and hd are the heights of 
shall and deep lanes, respectively, and ∆L means the flow distance along the channel.  
Thus, the geometry difference of multi-height lane generates a pressure force acting 
from the shallow lane toward the deep lane which can create additional force to transport 
particles across the barrier (Fig. 6.2a). 
This is confirmed by examine the flow pattern of two dye labeled parallel 
streams, where dye is initially transported across the barrier (Fig. 6.2b). This observation 
is no different when flow rate is higher to 2 mL/min or slower down to 0.1 mL/min. Fig. 
6.2c shows the effect of this pressure mismatch on particle migration. The initial 
migration from the shallow lane to the deep lane follows the dye flow (Fig. 6.2d).  These 
separated particles become focused at high flow rates (or high Re) along the channel 
wall. Farther downstream,the pressure difference becomes equalizedand particles in deep 
region concentrate near the barrier where they are influenced by life force and are able to 
migrate back into the shallow region (Fig. 6.2e). 
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Figure 6.2.Barrier embedded in straight channels with height difference. (a) 
Schematic of cross section of uneven height straight microchannel. (b) Two streams 
labeled with blue and yellow dye in a straight microchannel at the flow rate of 2 mL/min 
(shallow and deep lanes: 20 µm and 40 µm, respectively, centerline barrier gap: 7 µm 
deep). (c) Two parallel streams were co-injected into uneven height of microchannels. 
Sample stream was injected through sallow lane while buffer stream was in deep lane. 
(d) Separation of particles happens initially in upstream of channel.  The particles across 
the barrier in deep lane start focusing along the barrier wall at high flow rate. (e) In the 
downstream region, particles can move freely from deep lane back to shallow channel. 
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6.5 Combination of Uneven Height and Curved Channels 
In the previous care of an uneven height straight channel, particle transport in the 
downstream region becomes randomly distributed as the lateral pressure difference 
equalizes. We, therefore, explored incorporating a curved region into this “free” 
movement zone to generate secondary flow that reinforces particle migration to enhance 
separation efficiency (Fig. 6.3a). In Fig. 6.3b, small portion of blue dye can cross barrier 
in the entry section of channel to the outer lane due to the effect of pressure difference 
caused by uneven height and continue to move outward due to the Dean force at high 
flow rates. 
In Fig. 6.3c, we can observe the corresponding particle trajectories. Initially, 
particles are transported to the outer lane by the pressure difference due to uneven 
heights. Once the particles cross the barrier, they also experience a transverse Dean flow 
upon entering the curved region.This makes it difficult for the separated particles to re-
enter the sample stream (Fig. 6.3d). In this design, the passive secondary flow caused by 
pressure difference of uneven height acts together with the Dean flow together to 
achieve enhancement of particle separation. 
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Figure 6.3.An advanced separation device incorporated with uneven and curved 
channels. (a) A schematic of the cross section shows the primary separation driven by 
height difference and the secondary separation driven by curved geometry can enhance 
the migration of particles. (b) Two streams labeled with blue and yellow dye in a straight 
microchannel at the flow rate of 2 mL/min (shallow and deep lanes: 20 µm and 40 µm, 
respectively, centerline barrier gap: 7 µm deep, radius of curvature: 500 µm). (c) The 
fluorescent image of particle stream confirmed the assumption of particle migration. (d) 
Top view of fluoresce stream image to show overall movement of particles.  
  
 96 
 
6.6 Separation Efficiency 
To determine separation efficiency, separated particles were collected from two 
outlet streams and analyzed by Coulter counter and hemocytometer. Separation 
efficiency is quantitatively defined as the fraction of particles that cross the barrier Nb / 
Ns= (Cb x Vb) / (Cs x Vs), where Nb and Ns are total number of particles collected in 
buffer stream and sample stream, respectively. Cb and Cs are particle concentration of 
buffer and sample stream measured by Coulter counter. Vb and Vs are total volume of 
buffer and sample collected at the same time. This observation was also evaluated by the 
computational simulation calculated by STAR-CCM+ (CD-adapco) to verify the fraction 
of 2 µm particlescrossing the barrier to the outer lane. In Fig. 6.4a, the separation 
efficiency of an even height curved channel is low. As the flow rate increases the 
transverse Dean vortices enhance separation by transporting more particles across the 
barrier. Although the separation efficiency is still below 5% at high flow rates, it gives 
us a clue that the Dean force in the curved region cannot act alone asthe major force to 
separate particles but can enhance the efficiency at high flow rates.  
Separation efficiencies in multi-height channels with a central embedded barrier 
are dramatically increased.The transverse force caused by the entry pressure difference 
significantly impacts particle separation. Unlike other passive hydrodynamics in 
microchannels (i.e. diffusion dominated cross-flow filtration), this transverse pressure 
drop driven by uneven height lanes provides a new separation concept simply affected 
by channel geometry. In Fig. 6.4b, at low flow rate (0.1 mL/min), the particle separation 
efficiency increases to about 70%. However, when the flow rate is increased to 2 
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mL/min, the separation efficiency drops 10-20 % because the particles tend to focus near 
the centerline barrier and experience a shorter residence time to cross the barrier. 
According to the previous equation described internal pressure in a rectangular 
microchannel, pressure drop is inversely proportional to the cube of channel height if at 
the same flow rate, and even a slight change of height difference will cause channel 
pressure gradient with a large scale of change. To verify this hypothesis, we constructed 
another separation device with smaller channel height difference (40-7-30 (deep-gap-
shallow) µm) to observe the separation efficiency caused by channel height and obtained 
separation efficiency from counting of particles in inner and outer lanes. From Fig. 6.4c 
the separation efficiency drops almost two times (from 70 % to 35 %) at lower flow rate 
(0.1 mL/min). Similar separation efficiency is also observed when increasing of flow 
rate. 
By combining pressure and Dean forces, lateral particle migration and separation 
efficiency can be enhanced up to 80 %,even at high from rates (Fig. 6.4d). Compared to 
all of the separation efficiency data, we can conclude that the pressure drop force caused 
by the channel height difference is the major driving force to induce migration of 
particles across the barrier. But, the Dean force in the curved channel also plays a crucial 
role in dispersing the separated particles after the entry pressure difference becomes 
equalized. 
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Figure 6.4.Separation efficiency of particles in different scenarios of microfluidic 
separators. Output samples were collected and analyzed to obtain separation efficiency 
at different flow rate. Experimental (dots) and computational simulation (dash line) 
results show in (a) curved microchannel with 40-5-40 (inner-gap-outer) µm of cross 
section; (b) straight microchannel with 40-7-20 (deep-barrier-shallow) µm; (c) straight 
microchannel with 40-7-30 (deep-barrier-shallow) µm; (d) curved microchannel with 
40-7-20 (inner-gap-outer) µm. All experimental data were analyzed from three different 
devices. 
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6.7 MembranelessMicrofluidic Filtration 
After knowing the separation mechanism, we next constructed a membraneless 
filter employing a tunable weir-like centerline barrier embedded within a microchannel 
that follows a curved flow path by enzymatic micromachining(Fig. 6.5a). In this way, 
the resulting centrifugal forces act to transport suspended components across the 
centerline barrier from the inside wall to the outside wall207, with only those smaller than 
the barrier gap able to pass across. This separation mechanism is distinct from 
conventional cross-flow filtration methods where devices are specifically designed to 
suppress inertial effects125, 129, 130, 222, 223. The membraneless arrangement does not 
impose an excessive pressure drop and is less susceptible to clogging because the barrier 
is oriented parallel to the flow direction rather than perpendicular to it so that the 
primary flow continually sweeps material downstream. This approach is most effective 
at high flow rates where the curvature-induced forces are maximized, making it ideally 
suited for high-throughput processing of large sample volumes. 
We assessed filtration efficiency by injecting a mixture of fluorescent 
polystyrene beads of diameter 3 and 10 µm (1.68 x 106 and 4.55 x 104 particles/mL, 
respectively; 1:37 concentration ratio) into the inner inlet of the microchannelshown in 
Fig. 6.5aat a flow rate of 1.2 mL/min (water was co-injected into the outer inlet at the 
same flow rate), ), after which samples were collected at outlets positioned at the inner 
and outer sides of the centerline barrier and analyzed by fluorescence microscopy (Fig. 
6.5b). Separation was observed above a threshold flow rate of about0.1 mL/min, 
consistent with the combination of pressure difference and Dean flow effect. Under these 
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conditions, the 10 µm beads were unable to pass across the barrier and were therefore 
confined to the inner outlet, while the outer outlet contained only 3 µm beads—the only 
species able to cross the barrier. Analysis of serial dilutions using flow cytometry 
demonstrated ability to isolate the 10 µm beads with > 98% normalized efficiency at a 
concentration ratio of 104 (Fig. 6.6). 
Inertially driven flow and particle migration in conduits with complex 
asymmetric cross sectional geometries has been investigated by observing the particle 
streams. Furthermore, key features of the underlying flow phenomena governing 
filtration can also be inferred from 3D computational fluid dynamics simulations in the 
same geometry of previous device (Fig. 6.7a). The circulatory flow field established in 
the curved segment of the microchannel provides a centrifugal driving force for transport 
from the inner half to the outer half of the curved flow path—an effect that is enhanced 
by the unequal depths on each side of the central barrier (Fig. 6.7b). The simulation of 
velocity field result gave us an overlook that the secondary flow was directed from inner 
lane toward outer lane. In addition, the symmetrically counter rotating vortices occurred 
in curved region can be demonstrated in different aspect ratio of channels. The resulting 
particle advection becomes evident from Lagrangian tracking of 3 µm diameter beads, 
indicating that 61% are transported from the inner to the outer channel by the time they 
reach the end of the curved segment (Fig. 6.7c). 
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Figure 6.5.Size-selective filtration of a mixture of 3 and 10 µm beads.(a)Schematic 
and cross-sectional profile of a U-shaped microchannel fabricated using the method 
shown in Fig. 5.5. The width and radius of curvature of the microchannel are 300 and 
500 µm, respectively. The depths of the inner and outer channels are 13 µm and 20 µm, 
respectively, while the centerline has a 6 µm barrier gap. The central machining port was 
blocked during filtration.Above a sufficiently high flow rate, the 3 µm beads are driven 
across the 6 µm barrier by secondary centrifugal flow established in the curved 
microchannel segment. The 10 µm beads are filtered by remaining confined in the inner 
flow lane. (b) A mixture of 3 µm (1.68 x 106 particles/ml) and 10 µm (4.55 x 104 
particles/ml) fluorescent microspheres is injected through inner channel of the U-shape 
device at 1.2 mL/min. Only 3 µm beads were collected in outer outlet (no 10 µm beads 
were observed in 3 ml of collection). Enriched and concentrated 10 µm beads are 
collected from the inner outlet. 
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Figure 6.6.Analysis of particle separation capability.Flow cytometry data are shown 
for (a) the injected mixture of 3 and 10 µm beads at concentrations of 1.68 x 106 and 
4.55 x 102 particles/mL, respectively; (b) the sample collected from the inner outlet; and 
(c) the sample collected from the outer outlet. (d) Normalized particle counts of 10 µm 
beads recovered from the inner outlet. Data are shown for mixtures injected at 
concentration ratios of 3:10 µm beads ranging from 1:37 to 1:37,000. The red box 
denotes conditions shown in (a–c), where the collection efficiency approaches 100%. 
Beads were analyzed on a FACSCalibur flow cytometer (Becton Dickinson), equipped 
with a 15 mW air-cooled argon laser, using CellQuest acquisition software. Green 
fluorescence was collected through a 530/30 nm bandpass filter. List mode data were 
acquired and analyzed using FlowJo (version 8.8.6, Treestar, Inc.). 
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Figure 6.7.Computational simulation of membraneless filtration.(a) Simulated 
microchannel geometry matching the filtration device shown in Fig. 6.5. (b) Cross-
sectional view of the steady-state transverse component of the velocity field in the 
curved segment (position 2). Distinct counter-rotating vortices are evident on each side 
of the centerline barrier (500 µm radius of curvature, 1 mL/min flow rate). 
(c)Lagrangian tracking analysis shows the transport of 3 µm particles from the inside to 
the outside of the curved flow path as they travel from inlet (position 1) to outlet 
(position 3) 
  
 104 
 
To demonstrate practical application, we next used this filtration device to 
harvest PC3 human prostate cancer cells (20–30 µm diameter) from whole blood 
(injected component densities: PC3-1.43x106 cells/mL, WBC-1.22x106 cells/mL, RBC-
7.32x108 cells/mL) (Fig. 6.8a). The PC3-spiked blood sample was injected into the inner 
lane at 1 mL/min (PBS was co-injected into the outer lane at the same flow rate) and 
separated samples were collected from inner outlet and outer outlet.In Fig. 6.8b, red 
fluorescent dyed PC3 cells were collected in inner outlet and none of PC3 cells were 
observed in outer outlet. To be noticed, when collected cells were observed under a 
microscope, sample collected in inner outlet showed higher cell density and has a half 
reduction of volume compared to the original cell mixture injected from inner inlet. 
In order to quantitatively verify the device performance, the collected samples 
were analyzed by cell counting methods. Cell counts indicate that PC3 cells were 
harvested with more than 99% efficiency and 1.6-fold enrichment upon recovery from 
the inner lane (45% of RBCs, 4% of WBCs, and less than 1% of PC3 cells cross to the 
outer lane in Fig.6.8c). The enriched cells were maintained in the as-injected blood 
environment with no discernible change in viability (before filtration: 98.7 ± 0.6%, n = 
3; after filtration: 98.9 ± 0.1%, n = 3; Fig.6.8d). 
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Figure 6.8.An enzymatically machined membraneless architecture enables high-
throughput cell harvesting. (a) Illustration and cross-sectional profile (inner and outer 
lanes: 20 and 35 mm deep, respectively, centerline barrier gap: 3 mm deep, radius of 
curvature: 500 mm). (b) Separation of whole blood spiked with PC3 cancer cells at 1 
mL/min, showing isolation and enrichment of PC3 cells from whole blood (inner lane). 
(c) Cell-count data show the relative fractions of WBCs, RBCs, and PC3 cells recovered 
at the inner lane. (d) Viability of PC3 cells is unchanged after filtration (trypan blue 
assay, viable cells unstained; bar, 50 mm). 
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6.8 Summary 
We demonstrate size-based isolation and enrichment of cells from whole blood 
with throughput 1 – 2 orders of magnitude faster than currently possible. Separation is 
achieved using an enzymatically machined filtration architecture that uniquely merges 
the high selectivity of a physical membrane barrier with the ability to operate at high 
flow rates (mL/min range). This design makes it possible to process large volumes with 
no clogging, while simultaneously preserving cell viability. 
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CHAPTER VII 
CONCLUSIONS 
 
The novel fabrication methods described in this dissertation has make new 
contributions toward the goal of producing 3D microchannel networks mimicking the 
features of physiological vasculature.These techniques are likely to play a key role in 
enabling culture of functional organ-sized engineered tissues.A key future challenge will 
be to ensure convergence between the science and engineering associated with these 
microchannel network construction approaches, and the biology associated with 
incorporating this technology into the broader scope of life science applications. This 
shift toward the biological aspects of the problem introduces new considerations. For 
example, as the complexity of tissue engineering constructs continues to evolve it 
becomes increasingly important to maintain some degree of standardization with respect 
to experimental conditions. This is evident when considering the array of conditions 
already employed in microchannel-based cell culture studies. Meaningful comparisons 
between results obtained by different research groups are possible only if common cell 
types and culture conditions are consistently employed. Improved methods to seed and 
culture cells in extended 3D spaces also need to be developed and refined. Current 
microscopy-based approaches to observe cell culture in thin planar multiwell plate 
formats are inadequate to probe conditions deep within the interior of cm-sized 
constructs. Other key challenges involve embedding vasculature into porous scaffold 
substrates and developing methods amenable to mass production. Overcoming these 
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barriers promises to set the stage for a host of exciting developments in the field of tissue 
engineering during the coming years.Specific conclusions of all investigations described 
in this dissertation are summarized below.  
 
7.1 Electrostatic Discharge Constructed 3D Microvascular Networks 
The qualitative and quantitative resemblance of these branched 3D microchannel 
networks to anatomical vascular trees is remarkable in terms of both global architecture 
and local morphology. In addition to providing a convenient platform to study transport 
and flow in branched 3D microfluidic networks, these similarities introduce the exciting 
possibility of harnessing electrostatic discharge phenomena as a new tool to embed 
vascular networks in tissue scaffold materials so they can support cell culture throughout 
much larger volumes than are currently possible. Unlike conventional microfabrication 
processes, this method enables large-scale bio-inspired 3D flow networks containing a 
wide range of channel dimensions to be instantaneously constructed in a straightforward 
non-serial manner amenable to mass-production. 
 
7.2 Air Deformation Process Enlarged 3D Microvascular Networks 
Inflation process makes it possible for fabrication of artificial microvascular 
networks which can mimic the living system via a simple and rapid method. Unlike 
conventional microfabrication processes, hot-molding and pressurized air inflation 
methods together enable a bio-mimicked flow networks containing a desired range of 
channel dimensions to be simply constructed from 2D patternablemicrochannels. This 
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deformation process is also tunable globally increase the diameters of every channel 
inside a thermoplastic PLA substrate andmicrochannels with rectangular cross section to 
deform into circular as well as elliptic. The morphology of microchannelscan be further 
tuned by manipulating properties of rubbery nature of the thermoplastic polymer. For 
example, polypropylene and polystyrene are other thermoplastic polymers can also be 
used by those methods to construct circular 3D microvascular networks for a variety of 
biological mass transported applications. 
Moreover, we have successfully applied this technique to not only enlarge the 
channels diameter but also to smoothen the channel walls ofphysiologically similar 3D 
vasculature fabricated by electrostatic discharge. Finally, we showed that endothelial 
cells can be seeded and cultured inside biocompatible and biodegradable polymer PLA 
to form an endothelial layer around branched and interconnected microchannels. We 
believe that this microvascular device combined with an automated circulating perfusion 
system can as a platform to study rheology of blood flow potential drug discovery. 
 
7.3 Enzymatic Sculpted Surface Topographies 
Enzymatic machining introduces an unexplored avenue to fashion molecularly 
imprinted surface features mimicking those in living systems via a simple process that 
can be accessed in virtually any laboratory. More broadly, the highly-specific nature of 
the governing interactions lays a foundation to exquisitely control the templatednano-
scale morphologies by manipulating properties of the enzyme and substrate. For 
example, various classes of biodegradable polymers are selectively machined by 
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different enzymes For example, polycaprolactone (PCL) can be degraded by lipase224, 
and numerous strains of the bacterial classes Firmicutes and Proteobacteria can degrade 
PCL, polyhydroxybutyrate, and polybutylene succinate225. These interactions can be 
further tuned by engineering enzymes displaying enhanced activities and specificities 
that can be toggled in response to environmental cues, as well as by employing 
substrates containing assembled crystalline morphologies. 
 
7.4 MembranelessHigh-Throughput Cell Separation 
A key benefit of our approach is the capability for highthroughput operation, and 
this can be seen upon comparison with existing methods for isolation of rare-cell 
biomarkers relevant to cancer (for example, circulating tumor cells (CTCs); Table 7.1; 
results are expressed in terms of normalized throughput representing the time to process 
1 mL of undiluted whole blood). Not only is our approach orders of magnitude faster 
than comparable methods, it also delivers 99.2 ± 0.2% (n = 3) retention of PC3 cells 
from spiked whole blood and 99.7 ± 0.5% (n = 3) when dispersed in PBS buffer. No 
additional steps are required to retrieve the separated cells, in contrast to conventional 
membrane or affinity capture approaches. These advantages suggest considerable 
untapped potential to enable a wide range of blood-cell analysis applications where 
harvesting throughput is currently a limiting constraint (for example, granulocyte 
isolation204, 226cancercell analysis119). 
In the context of CTC analysis, we remark that immunoselection (the current 
gold standard) requires pre-programming with antibodies to enable recognition of 
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specific epithelial antigens expressed by CTCs, thus limiting the ability to capture 
different cell types and introducing the possibility of retaining non-malignant cells. 
Optimal capture efficiencies are achieved by applying low flow rates and increasing the 
binding surface area (requiring more antibodies), with additional wash steps and 
reagents necessary to recover the captured cells. CTCs have also been efficiently 
separated by dielectrophoresis, but the cells must be dispersed in isotonic buffers at high 
dilution, and low flow rates are required. Physical barrier filtration architectures also 
achieve high separation efficiency, but high dilution and low flow rates are needed to 
prevent clogging. Methods exploiting other hydrodynamic effects also generally require 
high dilution and often operate within a narrow “sweet spot” of cell size and flow rate. 
Our approach overcomes these throughput limitations because separation occurs 
optimally at high flow rates, with considerable potential for further improvement by 
employing multistage designs that sequentially feed the enriched effluent into additional 
downstream filtration elements. Multiple weirs with different widths, depths, and gaps 
can also be arrayed in parallel to process multicomponent mixtures. 
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Table 7.1.Comparison of microfluidic-based CTC enrichment methods. 
(Normalized throughput represents the time to process 1 mL of undiluted whole blood) 
 
Method Flow Rate (reported) 
Dilution 
Factor 
Normalized 
Throughput 
(mL min–1) 
CTC 
recovery Ref. Comments 
This work 1 mL min–1 5 0.2 99 % – • Optimal operation 
at high flow rates 
Immunoselection(
bead-based) 
10 mL h–1 > 1* unknown* 90 % 227
 
• Antibody-based 
• Additional washing 
240 µL min–1 > 1* unknown* 85 % 228
 
Immunoselection(
micropost array) 
1 mL h–1 1 0.017 65–80 % 119
 • Antibody-based 
• Low volume 
capacity 
 
1 mL h–1 1 0.017 95 % 229
 
2 mL h–1 1 0.03 92 % 230
 
Dielectrophoresis 
1.5 ml min–1 40,000 3.75 x 10–5 90 % 121
 
• Special buffer 
conditions 126 µL min–1 400 3.15 x 10–4 75 % 231
 
Physical barrier     
 • Dilution and/or low 
flow rate operation 
needed to avoid 
clogging 
• Pool-dam 0.1 mL min–1 5,000 2 x 10–5 99 % 125
 
• Isolation wells 0.7 mL h–1 3 3.9 x 10–3 80 % 128
 
Hydrodynamics     
 
• Dilution and/or low 
flow rate operation 
needed to avoid 
clogging 
• Expansion/ 
contraction  
0.4 mL min–1 20 0.02 80 % 232
 
• Microvortex 
trapping 
4.5 mL min–1 40 0.11 85 % 233
 
* Normalized throughput is difficult to assess due to the incubation, washing, and 
resuspensionsteps inherent to bead-based capture protocols. 
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